BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310. [PMID: 11558866 DOI: 10.1016/s0149-2918(01)80109-0] [Cited by in Crossref: 1456] [Cited by in F6Publishing: 469] [Article Influence: 76.6] [Reference Citation Analysis]
Number Citing Articles
1 Dhaliwal P, Wagg A. Overactive bladder: strategies to ensure treatment compliance and adherence. Clin Interv Aging 2016;11:755-60. [PMID: 27350744 DOI: 10.2147/CIA.S69636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Berger WE. New approaches to managing asthma: a US perspective. Ther Clin Risk Manag 2008;4:363-79. [PMID: 18728834 DOI: 10.2147/tcrm.s1382] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
3 Sayner R, Carpenter DM, Blalock SJ, Robin AL, Muir KW, Hartnett ME, Giangiacomo AL, Tudor G, Sleath B. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Clin Ther 2015;37:1975-85. [PMID: 26164785 DOI: 10.1016/j.clinthera.2015.06.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Bortnick AE, Epps KC, Selzer F, Anwaruddin S, Marroquin OC, Srinivas V, Holper EM, Wilensky RL. Five-year follow-up of patients treated for coronary artery disease in the face of an increasing burden of co-morbidity and disease complexity (from the NHLBI Dynamic Registry). Am J Cardiol 2014;113:573-9. [PMID: 24388624 DOI: 10.1016/j.amjcard.2013.10.039] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
5 Hylands-White N, Duarte RV, Raphael JH. An overview of treatment approaches for chronic pain management. Rheumatol Int. 2017;37:29-42. [PMID: 27107994 DOI: 10.1007/s00296-016-3481-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
6 Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA 2010;304:1592-601. [PMID: 20940385 DOI: 10.1001/jama.2010.1482] [Cited by in Crossref: 208] [Cited by in F6Publishing: 142] [Article Influence: 18.9] [Reference Citation Analysis]
7 Assari S, Bazargan M. Polypharmacy and Psychological Distress May Be Associated in African American Adults. Pharmacy (Basel) 2019;7:E14. [PMID: 30682807 DOI: 10.3390/pharmacy7010014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Mansur N, Weiss A, Hoffman A, Gruenewald T, Beloosesky Y. Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging 2008;25:861-70. [PMID: 18808210 DOI: 10.2165/00002512-200825100-00005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
9 Schindler E, Hohmann C, Culmsee C. Medication Review by Community Pharmacists for Type 2 Diabetes Patients in Routine Care: Results of the DIATHEM-Study. Front Pharmacol 2020;11:1176. [PMID: 32903568 DOI: 10.3389/fphar.2020.01176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mastrandrea LD. Inhaled insulin: overview of a novel route of insulin administration. Vasc Health Risk Manag 2010;6:47-58. [PMID: 20234779 DOI: 10.2147/vhrm.s6098] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
11 Ernst LL, Harden CL, Pennell PB, Llewellyn N, Lau C, Barnard S, Bartfeld E, French JA. Medication adherence in women with epilepsy who are planning pregnancy. Epilepsia 2016;57:2039-44. [PMID: 27778312 DOI: 10.1111/epi.13586] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
12 Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response. Addict Behav 2013;38:2119-27. [PMID: 23435273 DOI: 10.1016/j.addbeh.2013.01.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
13 Riegel B, Lee CS, Ratcliffe SJ, De Geest S, Potashnik S, Patey M, Sayers SL, Goldberg LR, Weintraub WS. Predictors of objectively measured medication nonadherence in adults with heart failure. Circ Heart Fail 2012;5:430-6. [PMID: 22647773 DOI: 10.1161/CIRCHEARTFAILURE.111.965152] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
14 Tan RA, Corren J. Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma. Drug Des Devel Ther 2014;8:1555-61. [PMID: 25328383 DOI: 10.2147/DDDT.S36556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Bernal I, Domènech E, Garcia-Planella E, Marín L, Mañosa M, Navarro M, Cabré E, Gassull MA. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006;51:2165-9. [PMID: 17086434 DOI: 10.1007/s10620-006-9444-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
16 Volpato E, Banfi P, Pagnini F. A psychological intervention to promote acceptance and adherence to non-invasive ventilation in people with chronic obstructive pulmonary disease: study protocol of a randomised controlled trial. Trials 2017;18:59. [PMID: 28166828 DOI: 10.1186/s13063-017-1802-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Denker MG, Cohen DL. Resistant Hypertension and Renal Nerve Denervation. Methodist Debakey Cardiovasc J 2015;11:240-4. [PMID: 27057294 DOI: 10.14797/mdcj-11-4-240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
18 King MA, Pryce RL. Evidence for compliance with long-term medication: a systematic review of randomised controlled trials. Int J Clin Pharm 2014;36:128-35. [PMID: 24293307 DOI: 10.1007/s11096-013-9893-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Vrijens B, Claeys MJ, Legrand V, Vandendriessche E, Van de Werf F. Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). Br J Clin Pharmacol 2014;77:746-55. [PMID: 24868573 DOI: 10.1111/bcp.12275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Settineri S, Frisone F, Merlo EM, Geraci D, Martino G. Compliance, adherence, concordance, empowerment, and self-management: five words to manifest a relational maladjustment in diabetes. J Multidiscip Healthc 2019;12:299-314. [PMID: 31118655 DOI: 10.2147/JMDH.S193752] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
21 Stellefson M, Paige SR, Alber JM, Chaney BH, Chaney D, Apperson A, Mohan A. Association Between Health Literacy, Electronic Health Literacy, Disease-Specific Knowledge, and Health-Related Quality of Life Among Adults With Chronic Obstructive Pulmonary Disease: Cross-Sectional Study. J Med Internet Res 2019;21:e12165. [PMID: 31172962 DOI: 10.2196/12165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
22 Steinbaugh L, Szaflarski JP. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine. Drug Des Devel Ther 2010;4:337-42. [PMID: 21151621 DOI: 10.2147/DDDT.S11175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Södergård B, Halvarsson M, Lindbäck S, Sönnerborg A, Tully MP, Lindblad AK. Differences in adherence and motivation to HIV therapy--two independent assessments in 1998 and 2002. Pharm World Sci 2006;28:248-56. [PMID: 17066240 DOI: 10.1007/s11096-006-9036-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
24 Kardas P. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. Vasc Health Risk Manag 2007;3:235-42. [PMID: 17580734 DOI: 10.2147/vhrm.2007.3.2.235] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
25 Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med 2012;28:287-300. [PMID: 22500544 DOI: 10.1016/j.cger.2012.01.008] [Cited by in Crossref: 90] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
26 Hall RL, Willgoss T, Humphrey LJ, Kongsø JH. The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence 2014;8:775-88. [PMID: 24920889 DOI: 10.2147/PPA.S61248] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
27 Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008;19:811-8. [PMID: 17999022 DOI: 10.1007/s00198-007-0506-x] [Cited by in Crossref: 166] [Cited by in F6Publishing: 131] [Article Influence: 13.8] [Reference Citation Analysis]
28 Jamison J, Ayerbe L, Di Tanna GL, Sutton S, Mant J, De Simoni A. Evaluating practical support stroke survivors get with medicines and unmet needs in primary care: a survey. BMJ Open 2018;8:e019874. [PMID: 29526835 DOI: 10.1136/bmjopen-2017-019874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Adua E, Roberts P, Sakyi SA, Yeboah FA, Dompreh A, Frimpong K, Anto EO, Wang W. Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study. Clin Transl Med 2017;6:32. [PMID: 28879491 DOI: 10.1186/s40169-017-0162-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gold DT, Silverman S. Review of adherence to medications for the treatment of osteoporosis. Curr Osteoporos Rep 2006;4:21-7. [PMID: 16527004 DOI: 10.1007/s11914-006-0011-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
31 Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011;86:304-14. [PMID: 21389250 DOI: 10.4065/mcp.2010.0575] [Cited by in Crossref: 795] [Cited by in F6Publishing: 545] [Article Influence: 79.5] [Reference Citation Analysis]
32 Ikama MS, Nsitou BM, Loumouamou M, Kimbally-Kaky G, Nkoua JL. [Drug compliance and its factors in a group of hypertensive Congolese]. Pan Afr Med J 2013;15:121. [PMID: 24255727 DOI: 10.11604/pamj.2013.15.121.2435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Fuster V, Gambús F, Patriciello A, Hamrin M, Grobbee DE. The polypill approach - An innovative strategy to improve cardiovascular health in Europe. BMC Pharmacol Toxicol 2017;18:10. [PMID: 28166827 DOI: 10.1186/s40360-016-0102-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
34 De Smet PA, Denneboom W, Kramers C, Grol R. A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging 2007;24:733-60. [PMID: 17727304 DOI: 10.2165/00002512-200724090-00003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
35 Lee KSS, Yang J, Niu J, Ng CJ, Wagner KM, Dong H, Kodani SD, Wan D, Morisseau C, Hammock BD. Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways. ACS Cent Sci 2019;5:1614-24. [PMID: 31572788 DOI: 10.1021/acscentsci.9b00770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
36 Naidoo P, Peltzer K, Louw J, Matseke G, McHunu G, Tutshana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health 2013;13:396. [PMID: 23622516 DOI: 10.1186/1471-2458-13-396] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
37 Nevins TE. "Why do they do that?" The compliance conundrum. Pediatr Nephrol 2005;20:845-8. [PMID: 15912377 DOI: 10.1007/s00467-005-1926-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
38 Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med 2010;10:1. [PMID: 20051135 DOI: 10.1186/1471-2466-10-1] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 7.6] [Reference Citation Analysis]
39 Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 2008;70:1809-17. [PMID: 18305231 DOI: 10.1212/01.wnl.0000303814.13509.db] [Cited by in Crossref: 86] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
40 Morrison A, Stauffer ME, Kaufman AS. Defining medication adherence in individual patients. Patient Prefer Adherence 2015;9:893-7. [PMID: 26170639 DOI: 10.2147/PPA.S86249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
41 Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, Kinmonth AL; Support and Advice for Medication Trial Group. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract 2008;9:20. [PMID: 18405345 DOI: 10.1186/1471-2296-9-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
42 Mikhael EM, Jasim AL. Antibiotic-prescribing patterns for Iraqi patients during Ramadan. Patient Prefer Adherence 2014;8:1647-51. [PMID: 25473271 DOI: 10.2147/PPA.S73401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Patel MS, Davis MM, Lypson ML. The VALUE Framework: training residents to provide value-based care for their patients. J Gen Intern Med 2012;27:1210-4. [PMID: 22573146 DOI: 10.1007/s11606-012-2076-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
44 Pan L, Belloni P, Ding HT, Wang J, Rubino CM, Putnam WS. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers. Adv Ther 2017;34:2071-82. [PMID: 28808905 DOI: 10.1007/s12325-017-0594-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Hale ME, Laudadio C, Yang R, Narayana A, Malamut R. Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain. J Pain Res 2015;8:623-36. [PMID: 26396543 DOI: 10.2147/JPR.S83930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
46 Oung AB, Kosirog E, Chavez B, Brunner J, Saseen JJ. Evaluation of medication adherence in chronic disease at a federally qualified health center. Ther Adv Chronic Dis 2017;8:113-20. [PMID: 28815008 DOI: 10.1177/2040622317714966] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
47 Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 2007;167:1798-803. [PMID: 17846400 DOI: 10.1001/archinte.167.16.1798] [Cited by in Crossref: 219] [Cited by in F6Publishing: 183] [Article Influence: 15.6] [Reference Citation Analysis]
48 Krekeler BN, Broadfoot CK, Johnson S, Connor NP, Rogus-Pulia N. Patient Adherence to Dysphagia Recommendations: A Systematic Review. Dysphagia 2018;33:173-84. [PMID: 28965240 DOI: 10.1007/s00455-017-9852-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
49 Fan JH, Lyons SA, Goodman MS, Blanchard MS, Kaphingst KA. Relationship Between Health Literacy and Unintentional and Intentional Medication Nonadherence in Medically Underserved Patients With Type 2 Diabetes. Diabetes Educ 2016;42:199-208. [PMID: 26763625 DOI: 10.1177/0145721715624969] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
50 Denker MG, Cohen DL, Townsend RR. Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled? Curr Atheroscler Rep 2015;17:56. [PMID: 26289114 DOI: 10.1007/s11883-015-0535-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
51 Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF. Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence. Patient Prefer Adherence. 2014;8:391-399. [PMID: 24729687 DOI: 10.2147/ppa.s60213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
52 Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007;18:1023-31. [PMID: 17308956 DOI: 10.1007/s00198-006-0322-8] [Cited by in Crossref: 309] [Cited by in F6Publishing: 251] [Article Influence: 22.1] [Reference Citation Analysis]
53 Betteridge N, Boehncke WH, Bundy C, Gossec L, Gratacós J, Augustin M. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol 2016;30:576-85. [PMID: 26377041 DOI: 10.1111/jdv.13306] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
54 Volpe M, Tocci G. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic. Vasc Health Risk Manag 2012;8:371-80. [PMID: 22745561 DOI: 10.2147/VHRM.S28359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
55 Shrank WH. Helping our patients to adhere to chronic medications: a new arrow for the quiver. J Gen Intern Med 2011;26:1394-5. [PMID: 21979760 DOI: 10.1007/s11606-011-1909-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Bell SP, Saraf A. Risk stratification in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80. Prog Cardiovasc Dis 2014;57:197-203. [PMID: 25216619 DOI: 10.1016/j.pcad.2014.08.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
57 Grant SJ, Chang DH, Liu J, Wong V, Kiat H, Bensoussan A. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial. BMC Complement Altern Med 2013;13:104. [PMID: 23672597 DOI: 10.1186/1472-6882-13-104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
58 Borghi C, Tartagni E. The older patient with hypertension: care and cure. Ther Adv Chronic Dis 2012;3:231-6. [PMID: 23342238 DOI: 10.1177/2040622312452189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
59 Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S. Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study. Clinicoecon Outcomes Res 2014;6:401-7. [PMID: 25258545 DOI: 10.2147/CEOR.S66338] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
60 Sanguinetti CM. The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients. Multidiscip Respir Med 2014;9:19. [PMID: 24690294 DOI: 10.1186/2049-6958-9-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
61 Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol 2009;21:356-62. [PMID: 19412103 DOI: 10.1097/BOR.0b013e32832c6aa4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
62 Torkildsen G, Narvekar A, Bergmann M. Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model. Clin Ophthalmol 2015;9:1703-13. [PMID: 26392751 DOI: 10.2147/OPTH.S83263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
63 Lavan R, Armstrong R, Normile D, Vaala W. Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA. Parasit Vectors 2020;13:541. [PMID: 33129346 DOI: 10.1186/s13071-020-04415-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res 2009;14:185-90. [PMID: 19541573 DOI: 10.1186/2047-783x-14-5-185] [Cited by in Crossref: 71] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
65 Roig J, Hernando R, Mora R. Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist. Open Respir Med J 2009;3:27-30. [PMID: 19452036 DOI: 10.2174/1874306400903010027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
66 Pamboukian SV, Nisar I, Patel S, Gu L, McLeod M, Costanzo MR, Heroux A. Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients. Clin Cardiol 2008;31:30-4. [PMID: 18203116 DOI: 10.1002/clc.20175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
67 Ulloa CM, Towfigh A, Safdieh J. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatr Dis Treat 2009;5:467-76. [PMID: 19777068 DOI: 10.2147/ndt.s4844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
68 Gewirtz A, Minen M. Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence. Curr Pain Headache Rep 2019;23:3. [PMID: 30661135 DOI: 10.1007/s11916-019-0739-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
69 Arievich H, Overend T, Renard D, Gibbs M, Alagappan V, Looby M, Banerji D. A novel model-based approach for dose determination of glycopyrronium bromide in COPD. BMC Pulm Med 2012;12:74. [PMID: 23217058 DOI: 10.1186/1471-2466-12-74] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
70 Payne SC, Ward G, MacIsaac RJ, Hyakumura T, Fallon JB, Villalobos J. Differential effects of vagus nerve stimulation strategies on glycemia and pancreatic secretions. Physiol Rep 2020;8:e14479. [PMID: 32512650 DOI: 10.14814/phy2.14479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Regnault A, Viala-Danten M, Gilet H, Berdeaux G. Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment. BMC Ophthalmol 2010;10:1. [PMID: 20122146 DOI: 10.1186/1471-2415-10-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
72 Buurma M, van Diemen JJK, Thijs A, Numans ME, Bonten TN. Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin. Front Cardiovasc Med 2019;6:84. [PMID: 31281821 DOI: 10.3389/fcvm.2019.00084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
73 Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: an overview of systematic reviews. Eur J Hosp Pharm 2019;26:187-92. [PMID: 31338165 DOI: 10.1136/ejhpharm-2018-001725] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 9.7] [Reference Citation Analysis]
74 Glezer MG, Vygodin VA; ODA investigators. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice. Adv Ther 2018;35:1368-77. [PMID: 30105656 DOI: 10.1007/s12325-018-0756-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
75 Virchow JC, Akdis CA, Darba J, Dekhuijzen R, Hartl S, Kobelt G, Roger A, Simoens S, Toumi M, Woodhouse B, Plich A, Torvinen S. A review of the value of innovation in inhalers for COPD and asthma. J Mark Access Health Policy 2015;3. [PMID: 27123170 DOI: 10.3402/jmahp.v3.28760] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
76 Witticke D, Seidling HM, Klimm HD, Haefeli WE. Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Prefer Adherence 2012;6:679-84. [PMID: 23055701 DOI: 10.2147/PPA.S35950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
77 Nevins TE, Thomas W. Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 2009;87:711-8. [PMID: 19295316 DOI: 10.1097/TP.0b013e318195c3d5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
78 Lewis S, Kink S, Rahl M, Nord A, Meldau J, Roberts K. Aspirin: are patients actually taking it?-A quality assessment study. Arthroplast Today 2018;4:475-8. [PMID: 30560179 DOI: 10.1016/j.artd.2018.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
79 Adams LV, Talbot EA, Odato K, Blunt H, Steingart KR. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis 2014;14:281. [PMID: 24886159 DOI: 10.1186/1471-2334-14-281] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
80 Costantine MM, Matok I, Chiossi G, Clark S, Miodovnik M, Umans JG, Caritis S, Hankins GD, Koren G. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Ther Drug Monit 2012;34:569-73. [PMID: 22972538 DOI: 10.1097/FTD.0b013e31826e7997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
81 Biton V, Shneker BF, Naritoku D, Hammer AE, Vuong A, Caldwell PT, Messenheimer JA. Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials. Clin Drug Investig 2013;33:359-64. [PMID: 23475541 DOI: 10.1007/s40261-013-0070-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
82 Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31:213-224. [PMID: 18202907 DOI: 10.1007/s10865-007-9147-y] [Cited by in Crossref: 307] [Cited by in F6Publishing: 242] [Article Influence: 23.6] [Reference Citation Analysis]
83 Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis 2016;41:187-205. [PMID: 26780746 DOI: 10.1007/s11239-015-1319-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 11.6] [Reference Citation Analysis]
84 Yasuda H, Hotta N, Nakao K, Kasuga M, Kashiwagi A, Kawamori R. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. J Diabetes Investig 2011;2:132-9. [PMID: 24843472 DOI: 10.1111/j.2040-1124.2010.00073.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
85 Kjellström B, Sandqvist A, Hjalmarsson C, Nisell M, Näsman P, Ivarsson B. Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. ERJ Open Res 2020;6:00299-2020. [PMID: 33313301 DOI: 10.1183/23120541.00299-2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Walker C, Puumala S, Golub LM, Stoner JA, Reinhardt RA, Lee HM, Payne JB. Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results. J Periodontol 2007;78:1590-601. [PMID: 17668979 DOI: 10.1902/jop.2007.070015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
87 Lindquist LA, Lindquist LM, Zickuhr L, Friesema E, Wolf MS. Unnecessary complexity of home medication regimens among seniors. Patient Educ Couns 2014;96:93-7. [PMID: 24793007 DOI: 10.1016/j.pec.2014.03.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
88 Irving G. Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians. Ther Adv Chronic Dis 2012;3:211-8. [PMID: 23342236 DOI: 10.1177/2040622312452905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
89 Souza-Machado A, Santos PM, Cruz AA. Adherence to treatment in severe asthma: predicting factors in a program for asthma control in Brazil. World Allergy Organ J 2010;3:48-52. [PMID: 23282417 DOI: 10.1097/WOX.0b013e3181d25e8e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
90 Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA. Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates. Pharmacoepidemiol Drug Saf 2010;19:1233-40. [PMID: 21108489 DOI: 10.1002/pds.2048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
91 Vo LNQ, Codlin AJ, Forse RJ, Nguyen HT, Vu TN, Van Truong V, Do GC, Nguyen LH, Le GT, Caws M. Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam. BMC Infect Dis 2020;20:134. [PMID: 32050913 DOI: 10.1186/s12879-020-4865-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
92 Hughes DA. Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens. Br J Clin Pharmacol 2008;65:871-8. [PMID: 18384445 DOI: 10.1111/j.1365-2125.2008.03124.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
93 Fan S, Ross C, Mitra S, Kalra P, Heaton J, Hunter J, Plone M, Pritchard N. A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis. Nephrol Dial Transplant. 2009;24:3794-3799. [PMID: 19666658 DOI: 10.1093/ndt/gfp372] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
94 Evon DM, Esserman DA, Bonner JE, Rao T, Fried MW, Golin CE. Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. J Viral Hepat 2013;20:536-49. [PMID: 23808992 DOI: 10.1111/jvh.12079] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
95 Sun AP, Kirby B, Black C, Helms PJ, Bennie M, McLay JS. Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study. BMC Pharmacol Toxicol 2014;15:11. [PMID: 24594374 DOI: 10.1186/2050-6511-15-11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Evon DM, Golin CE, Fried MW, Keefe FJ. Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? J Consult Clin Psychol 2013;81:361-74. [PMID: 22730952 DOI: 10.1037/a0029030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
97 Valentino K, De Alba A, Hibel LC, Fondren K, McDonnell CG. Adherence to Diurnal Cortisol Sampling Among Mother-Child Dyads From Maltreating and Nonmaltreating Families. Child Maltreat 2017;22:286-94. [PMID: 28819984 DOI: 10.1177/1077559517725208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
98 Berkman ET, Giuliani NR, Pruitt AK. Comparison of text messaging and paper-and-pencil for ecological momentary assessment of food craving and intake. Appetite 2014;81:131-7. [PMID: 24930596 DOI: 10.1016/j.appet.2014.06.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
99 Reginster JY, Felsenberg D, Cooper C, Stakkestad JA, Miller PD, Kendler DL, Adami S, McClung MR, Bolognese MA, Civitelli R, Dumont E, Bonvoisin B, Recker RR, Delmas PD. A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporos Int 2006;17:159-66. [PMID: 15959614 DOI: 10.1007/s00198-005-1957-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
100 Al-Hajje A, Awada S, Rachidi S, Zein S, Bawab W, El-Hajj Z, Zeid MB, Yassine M, Salameh P. Factors affecting medication adherence in Lebanese patients with chronic diseases. Pharm Pract (Granada) 2015;13:590. [PMID: 26445621 DOI: 10.18549/PharmPract.2015.03.590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
101 Meulendijk MC, Spruit MR, Drenth-van Maanen AC, Numans ME, Brinkkemper S, Jansen PA, Knol W. Computerized Decision Support Improves Medication Review Effectiveness: An Experiment Evaluating the STRIP Assistant's Usability. Drugs Aging 2015;32:495-503. [PMID: 26025118 DOI: 10.1007/s40266-015-0270-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
102 Maggiolo F. Efavirenz: a decade of clinical experience in the treatment of HIV. J Antimicrob Chemother 2009;64:910-28. [PMID: 19767318 DOI: 10.1093/jac/dkp334] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
103 Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004;15:1003-8. [PMID: 15167989 DOI: 10.1007/s00198-004-1652-z] [Cited by in Crossref: 353] [Cited by in F6Publishing: 273] [Article Influence: 20.8] [Reference Citation Analysis]
104 Mukhtar O, Weinman J, Jackson SH. Intentional non-adherence to medications by older adults. Drugs Aging 2014;31:149-57. [PMID: 24566876 DOI: 10.1007/s40266-014-0153-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
105 Abbass I, Revere L, Mitchell J, Appari A. Medication Nonadherence: The Role of Cost, Community, and Individual Factors. Health Serv Res 2017;52:1511-33. [PMID: 27558760 DOI: 10.1111/1475-6773.12547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
106 Jensen FF, Håkansson KEJ, Overgaard Nielsen B, Weinreich UM, Ulrik CS. Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma. Asthma Res Pract 2021;7:7. [PMID: 34059120 DOI: 10.1186/s40733-021-00072-2] [Reference Citation Analysis]
107 Chao CT, Huang JW; COGENT (COhort of GEriatric Nephrology in NTUH) study group. Geriatric syndromes are potential determinants of the medication adherence status in prevalent dialysis patients. PeerJ 2016;4:e2122. [PMID: 27326380 DOI: 10.7717/peerj.2122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
108 Assari S, Wisseh C, Bazargan M. Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator. Int J Environ Res Public Health 2019;16:E2181. [PMID: 31226752 DOI: 10.3390/ijerph16122181] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
109 Schulze-Bonhage A, Hintz M. Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability. Patient Prefer Adherence 2015;9:1143-51. [PMID: 26316718 DOI: 10.2147/PPA.S63951] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
110 Atassi N, Yerramilli-Rao P, Szymonifka J, Yu H, Kearney M, Grasso D, Deng J, Levine-Weinberg M, Shapiro J, Lee A, Joseph L, Macklin EA, Cudkowicz ME. Analysis of start-up, retention, and adherence in ALS clinical trials. Neurology 2013;81:1350-5. [PMID: 24005339 DOI: 10.1212/WNL.0b013e3182a823e0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
111 Wu JR, Moser DK, Chung ML, Lennie TA. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail 2008;14:603-14. [PMID: 18722327 DOI: 10.1016/j.cardfail.2008.02.011] [Cited by in Crossref: 123] [Cited by in F6Publishing: 101] [Article Influence: 9.5] [Reference Citation Analysis]
112 Landfeldt E, Ström O, Robbins S, Borgström F. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Osteoporos Int 2012;23:433-43. [PMID: 21286686 DOI: 10.1007/s00198-011-1549-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
113 Freeman MA, Myaskovsky L. An overview of disparities and interventions in pediatric kidney transplantation worldwide. Pediatr Nephrol. 2015;30:1077-1086. [PMID: 25315177 DOI: 10.1007/s00467-014-2879-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
114 Hsieh WT, Su YC, Han HL, Huang MY. A Novel mHealth Approach for a Patient-Centered Medication and Health Management System in Taiwan: Pilot Study. JMIR Mhealth Uhealth 2018;6:e154. [PMID: 29970356 DOI: 10.2196/mhealth.9987] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
115 Lavan R, Normile D, Husain I, Singh A, Heaney K. Analysis of gaps in feline ectoparasiticide purchases from veterinary clinics in the United States. Parasit Vectors 2021;14:264. [PMID: 34016157 DOI: 10.1186/s13071-021-04768-5] [Reference Citation Analysis]
116 Werz MA. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release. Ther Clin Risk Manag 2008;4:1035-46. [PMID: 19209284 DOI: 10.2147/tcrm.s3343] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
117 Blizzard C, Desai A, Driscoll A. Pharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle Dogs. J Ocul Pharmacol Ther 2016;32:595-600. [PMID: 27483129 DOI: 10.1089/jop.2016.0025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
118 Chung YS, Lim SK, Chung HY, Lee IK, Park IH, Kim GS, Min YK, Kang MI, Chung DJ, Kim YK, Choi WH, Shong MH, Park JH, Byun DW, Yoon HK, Shin CS, Lee YS, Kwon NH. Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. Calcif Tissue Int 2009;85:389-97. [PMID: 19816648 DOI: 10.1007/s00223-009-9294-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
119 Al Jurdi RK, Dixit LA, Sajatovic M. Role of extended release quetiapine in the management of bipolar disorders. Neuropsychiatr Dis Treat 2010;6:29-35. [PMID: 20361059 DOI: 10.2147/ndt.s4903] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
120 Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 2013;4:91. [PMID: 23898295 DOI: 10.3389/fphar.2013.00091] [Cited by in Crossref: 272] [Cited by in F6Publishing: 199] [Article Influence: 34.0] [Reference Citation Analysis]
121 Choi YJ, Lee DH, Choi MG, Lee SJ, Kim SK, Song GA, Rhee PL, Jung HY, Kang DH, Lee YC, Lee SH, Choi SC, Shim KN, Seol SY, Moon JS, Shin YW, Kim HS, Lee ST, Cho JW, Choi EK, Lee OY, Jang JS. Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study. J Korean Med Sci 2017;32:1807-13. [PMID: 28960033 DOI: 10.3346/jkms.2017.32.11.1807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
122 Akarırmak Ü, Koçyiğit H, Eskiyurt N, Esmaeilzadeh S, Kuru Ö, Yalçinkaya EY, Peker Ö, Ekim AA, Özgirgin N, Çalış M, Rezvani A, Çevikol A, Eyigör S, Şendur ÖF, İrdesel J; INSTRUCT Study Group. Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis. Acta Orthop Traumatol Turc 2016;50:415-23. [PMID: 27524671 DOI: 10.1016/j.aott.2016.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99. [PMID: 20836888 DOI: 10.1186/1477-7525-8-99] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 9.5] [Reference Citation Analysis]
124 Haase R, Kullmann JS, Ziemssen T. Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey. Ther Adv Neurol Disord 2016;9:250-63. [PMID: 27366231 DOI: 10.1177/1756285616634247] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
125 Silver HJ, Kang H, Keil CD, Muldowney JA 3rd, Kocalis H, Fazio S, Vaughan DE, Niswender KD. Consuming a balanced high fat diet for 16 weeks improves body composition, inflammation and vascular function parameters in obese premenopausal women. Metabolism 2014;63:562-73. [PMID: 24559846 DOI: 10.1016/j.metabol.2014.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
126 Fleig SV, Weger B, Haller H, Limbourg FP. Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study. Adv Ther 2018;35:353-66. [PMID: 29498018 DOI: 10.1007/s12325-018-0675-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
127 Evon DM, Golin CE, Stewart P, Fried MW, Alston S, Reeve B, Lok AS, Sterling RK, Lim JK, Reau N, Sarkar S, Nelson DR, Reddy KR, Di Bisceglie AM. Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment. Contemp Clin Trials 2017;57:58-68. [PMID: 28342989 DOI: 10.1016/j.cct.2017.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
128 Drenth-van Maanen AC, van Marum RJ, Knol W, van der Linden CM, Jansen PA. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 2009;26:687-701. [PMID: 19685934 DOI: 10.2165/11316400-000000000-00000] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
129 Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Cummins G, Galtrey C, Hellman B, Pal S, Stamford J, Steiger M, Williams A; SMART-PD Investigators. Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014). Trials 2014;15:374. [PMID: 25257518 DOI: 10.1186/1745-6215-15-374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
130 Epstein LH, Paluch RA, Stein JS, Quattrin T, Mastrandrea LD, Bree KA, Sze YY, Greenawald MH, Biondolillo MJ, Bickel WK. Delay Discounting, Glycemic Regulation and Health Behaviors in Adults with Prediabetes. Behav Med 2021;47:194-204. [PMID: 32275202 DOI: 10.1080/08964289.2020.1712581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Sasaki J, Weil AJ, Ross EL, Nicholson BD. Effectiveness of polymer-coated extended-release morphine sulfate capsules in older patients with persistent moderate-to-severe pain: A subgroup analysis of a large, open-label, community-based trial. Curr Ther Res Clin Exp 2007;68:137-50. [PMID: 24683205 DOI: 10.1016/j.curtheres.2007.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Reeve E, Wiese MD. Benefits of deprescribing on patients' adherence to medications. Int J Clin Pharm 2014;36:26-9. [PMID: 24242974 DOI: 10.1007/s11096-013-9871-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
133 Specht U. [Compliance with antiepileptic drugs]. Nervenarzt 2008;79:662-8. [PMID: 18231764 DOI: 10.1007/s00115-008-2408-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
134 Iqbal SA, Armstrong LR, Kammerer JS, Truman BI. Risk Factors for and Trends in Isoniazid Monoresistance at Diagnosis of Tuberculosis-United States, 1993-2016. J Public Health Manag Pract 2021;27:E162-72. [PMID: 31688735 DOI: 10.1097/PHH.0000000000001060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, Morton JM. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198-1204. [PMID: 19381735 DOI: 10.1007/s11605-009-0891-x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 96] [Article Influence: 10.5] [Reference Citation Analysis]
136 Willett KC, Morrill AM. Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence. Ther Clin Risk Manag 2017;13:447-54. [PMID: 28435279 DOI: 10.2147/TCRM.S88911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
137 Knafl GJ, Riegel B. What puts heart failure patients at risk for poor medication adherence? Patient Prefer Adherence 2014;8:1007-18. [PMID: 25114512 DOI: 10.2147/PPA.S64593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
138 Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES). Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 2007;18:1311-7. [PMID: 17585359 DOI: 10.1007/s00198-007-0410-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
139 Aungst A, Casady L, Dixon C, Maldonado J, Moreo N, Pearsall L, Robertson D. Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple Sclerosis. Clin Drug Investig 2020;40:73-81. [PMID: 31599395 DOI: 10.1007/s40261-019-00866-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
140 Zhang L, Lu S, Feng J, Dechaphunkul A, Chang J, Wang D, Chessari S, Lanzarotti C, Jordan K, Aapro M. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). Ann Oncol 2018;29:452-8. [PMID: 29092012 DOI: 10.1093/annonc/mdx698] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 15.5] [Reference Citation Analysis]
141 Okuyemi KS, Zheng H, Guo H, Ahluwalia JS. Predictors of adherence to nicotine gum and counseling among African-American light smokers. J Gen Intern Med 2010;25:969-76. [PMID: 20495885 DOI: 10.1007/s11606-010-1386-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
142 Wang KL, Fang CY, Lai WT, Wang TD, Ueng KC, Wang KY, Wang JH, Shyu KG, Chiang CE. Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial. Acta Cardiol Sin 2021;37:186-94. [PMID: 33716461 DOI: 10.6515/ACS.202103_37(2).20200914B] [Reference Citation Analysis]
143 Vidula MK, Wadhwani A, Roberts K, Berkowitz LL. Use of a once-daily NSAID in treatment of cyclic vomiting syndrome. J Gen Intern Med 2014;29:543-6. [PMID: 24129856 DOI: 10.1007/s11606-013-2624-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
144 Rodbard HW, Cariou B, Pieber TR, Endahl LA, Zacho J, Cooper JG. Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial. Diabetes Obes Metab 2016;18:274-80. [PMID: 26592732 DOI: 10.1111/dom.12609] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
145 Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM. Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial. BMJ Open 2015;5:e006131. [PMID: 25649209 DOI: 10.1136/bmjopen-2014-006131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
146 Walker EA, Gonzalez JS, Tripputi MT, Dagogo-Jack S, Matulik MJ, Montez MG, Tadros S, Edelstein SL; DPP Research Group. Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study. BMJ Open Diabetes Res Care 2020;8:e001537. [PMID: 33023898 DOI: 10.1136/bmjdrc-2020-001537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
147 Sun Y, Li C, Zhang L, Hu D, Zhang X, Yu T, Tao M, Wang DW, Shen X. Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients. Front Med 2017;11:53-61. [PMID: 28213881 DOI: 10.1007/s11684-017-0502-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
148 Adinkrah E, Bazargan M, Wisseh C, Assari S. Medication Complexity among Disadvantaged African American Seniors in Los Angeles. Pharmacy (Basel) 2020;8:E86. [PMID: 32429387 DOI: 10.3390/pharmacy8020086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Zinellu E, Piras B, Ruzittu GGM, Fois SS, Fois AG, Pirina P. Recent Advances in Inflammation and Treatment of Small Airways in Asthma. Int J Mol Sci 2019;20:E2617. [PMID: 31141956 DOI: 10.3390/ijms20112617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
150 Larrey D, Ripault MP, Pageaux GP. Patient adherence issues in the treatment of hepatitis C. Patient Prefer Adherence 2014;8:763-73. [PMID: 24920888 DOI: 10.2147/PPA.S30339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
151 Portaccio E, Amato MP. Improving compliance with interferon-beta therapy in patients with multiple sclerosis. CNS Drugs 2009;23:453-62. [PMID: 19480465 DOI: 10.2165/00023210-200923060-00001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
152 Kocis PT, Liu G, Makenbaeva D, Trocio J, Velott D, Trainer JB, Abdulsattar Y, Molina MI, Leslie DL. Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation. Drugs Real World Outcomes 2016;3:165-73. [PMID: 27398295 DOI: 10.1007/s40801-016-0072-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Pombo-Suarez M, Maneiro Fernandez JR, Gomez-Reino JJ. Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain. Patient Prefer Adherence 2021;15:111-7. [PMID: 33531797 DOI: 10.2147/PPA.S291983] [Reference Citation Analysis]
154 Harsha N, Kőrösi L, Pálinkás A, Bíró K, Boruzs K, Ádány R, Sándor J, Czifra Á. Determinants of Primary Nonadherence to Medications Prescribed by General Practitioners Among Adults in Hungary: Cross-Sectional Evaluation of Health Insurance Data. Front Pharmacol 2019;10:1280. [PMID: 31736757 DOI: 10.3389/fphar.2019.01280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Cotte L, Ferry T, Pugliese P, Valantin MA, Allavena C, Cabié A, Poizot-Martin I, Rey D, Duvivier C, Cheret A, Dellamonica P, Pradat P, Parienti JJ; Dat’AIDS study group. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study. PLoS One 2017;12:e0170661. [PMID: 28152047 DOI: 10.1371/journal.pone.0170661] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
156 Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 2011;26:1175-82. [PMID: 21533823 DOI: 10.1007/s11606-011-1704-y] [Cited by in Crossref: 285] [Cited by in F6Publishing: 205] [Article Influence: 28.5] [Reference Citation Analysis]
157 Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63:831-838. [PMID: 18728206 DOI: 10.1136/thx.2007.086041] [Cited by in Crossref: 254] [Cited by in F6Publishing: 246] [Article Influence: 19.5] [Reference Citation Analysis]
158 Shane AL, Cabana MD, Vidry S, Merenstein D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch SV, Sanders ME, Tancredi DJ. Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 2010;1:243-53. [PMID: 21327031 DOI: 10.4161/gmic.1.4.12707] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
159 Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. J Stud Alcohol Drugs 2008;69:878-84. [PMID: 18925346 DOI: 10.15288/jsad.2008.69.878] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
160 Vernacchio L, Corwin MJ, Vezina RM, Pelton SI, Feldman HA, Coyne-Beasley T, Mitchell AA. Xylitol syrup for the prevention of acute otitis media. Pediatrics 2014;133:289-95. [PMID: 24394686 DOI: 10.1542/peds.2013-2373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
161 Schlander M, Trott GE, Schwarz O. [The health economics of attention deficit hyperactivity disorder in Germany. Part 2: Therapeutic options and their cost-effectiveness]. Nervenarzt 2010;81:301-14. [PMID: 19936695 DOI: 10.1007/s00115-009-2889-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
162 Kendler DL, Bessette L, Hill CD, Gold DT, Horne R, Varon SF, Borenstein J, Wang H, Man HS, Wagman RB, Siddhanti S, Macarios D, Bone HG. Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass. Osteoporos Int 2010;21:837-46. [PMID: 19657689 DOI: 10.1007/s00198-009-1023-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
163 Tsai AC, Karasic DH, Hammer GP, Charlebois ED, Ragland K, Moss AR, Sorensen JL, Dilley JW, Bangsberg DR. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health 2013;103:308-15. [PMID: 22720766 DOI: 10.2105/AJPH.2011.300422] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
164 O'Byrne PM, Bleecker ER, Bateman ED, Busse WW, Woodcock A, Forth R, Toler WT, Jacques L, Lötvall J. Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma. Eur Respir J 2014;43:773-82. [PMID: 24136330 DOI: 10.1183/09031936.00064513] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
165 Falagas ME, Karagiannis AK, Nakouti T, Tansarli GS. Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials. PLoS One 2015;10:e0116207. [PMID: 25559848 DOI: 10.1371/journal.pone.0116207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
166 Straka I, Minár M, Gažová A, Valkovič P, Kyselovič J. Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review. Medicine (Baltimore) 2018;97:e10962. [PMID: 29879046 DOI: 10.1097/MD.0000000000010962] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
167 Nordmann JP, Baudouin C, Renard JP, Denis P, Regnault A, Berdeaux G. Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clin Ophthalmol 2010;4:1489-96. [PMID: 21191445 DOI: 10.2147/OPTH.S11818] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
168 Lötvall J, Bakke PS, Bjermer L, Steinshamn S, Scott-Wilson C, Crim C, Sanford L, Haumann B. Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open 2012;2:e000370. [PMID: 22267687 DOI: 10.1136/bmjopen-2011-000370] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
169 Kim YC, Chiang B, Wu X, Prausnitz MR. Ocular delivery of macromolecules. J Control Release 2014;190:172-81. [PMID: 24998941 DOI: 10.1016/j.jconrel.2014.06.043] [Cited by in Crossref: 128] [Cited by in F6Publishing: 104] [Article Influence: 18.3] [Reference Citation Analysis]
170 Abdul-Sattar AB, Abou El Magd SA. Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate. Rheumatol Int 2015;35:1045-51. [PMID: 25424491 DOI: 10.1007/s00296-014-3182-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
171 Jones SJ, Taylor AF, Beales PA. Towards feedback-controlled nanomedicines for smart, adaptive delivery. Exp Biol Med (Maywood) 2019;244:283-93. [PMID: 30205721 DOI: 10.1177/1535370218800456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
172 van Mierlo T, Fournier R, Fedorak R. Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR Mhealth Uhealth 2015;3:e5. [PMID: 25608628 DOI: 10.2196/mhealth.3987] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
173 Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, Haughney J, Henrichsen SH, Kaplan A, Langhammer A, Østrem A, Thomas M, van der Molen T, Virchow JC, Williams S. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8. [PMID: 17518999 DOI: 10.1186/1471-2466-7-8] [Cited by in Crossref: 119] [Cited by in F6Publishing: 126] [Article Influence: 8.5] [Reference Citation Analysis]
174 Murakami M, Osada K, Mizuno H, Ochiai T, Alev L, Nishioka K. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Res Ther 2015;17:224. [PMID: 26296539 DOI: 10.1186/s13075-015-0718-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
175 Greenley RN, Kunz JH, Walter J, Hommel KA. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1534-1545. [PMID: 23635715 DOI: 10.1097/mib.0b013e3182813482] [Cited by in Crossref: 52] [Cited by in F6Publishing: 16] [Article Influence: 7.4] [Reference Citation Analysis]
176 Pruette CS, Coburn SS, Eaton CK, Brady TM, Tuchman S, Mendley S, Fivush BA, Eakin MN, Riekert KA. Does a multimethod approach improve identification of medication nonadherence in adolescents with chronic kidney disease? Pediatr Nephrol 2019;34:97-105. [PMID: 30116892 DOI: 10.1007/s00467-018-4044-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
177 Kripalani S, Schmotzer B, Jacobson TA. Improving Medication Adherence through Graphically Enhanced Interventions in Coronary Heart Disease (IMAGE-CHD): a randomized controlled trial. J Gen Intern Med 2012;27:1609-17. [PMID: 22790614 DOI: 10.1007/s11606-012-2136-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
178 Tungaraza TE, Talapan-Manikoth P, Jenkins R. Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry. Ther Adv Drug Saf 2013;4:63-71. [PMID: 25083252 DOI: 10.1177/2042098612474681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
179 Desai SN, Badiger SV, Tokur SB, Naik PA. Safety and efficacy of transdermal buprenorphine versus oral tramadol for the treatment of post-operative pain following surgery for fracture neck of femur: A prospective, randomised clinical study. Indian J Anaesth 2017;61:225-9. [PMID: 28405035 DOI: 10.4103/ija.IJA_208_16] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
180 Billecke SS, Marcovitz PA. Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension. Vasc Health Risk Manag 2013;9:95-104. [PMID: 23662062 DOI: 10.2147/VHRM.S40963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
181 Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorb 2011;1:28-44. [PMID: 29090134 DOI: 10.15256/joc.2011.1.4] [Cited by in Crossref: 114] [Cited by in F6Publishing: 70] [Article Influence: 11.4] [Reference Citation Analysis]
182 Egert-Schmidt AM, Kolbe JM, Mussler S, Thum-Oltmer S. Patients' compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence 2014;8:1475-81. [PMID: 25368517 DOI: 10.2147/PPA.S70326] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
183 Philis-Tsimikas A. Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes. Patient Prefer Adherence 2008;2:323-32. [PMID: 19920979 DOI: 10.2147/ppa.s3293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
184 Hauber AB, Tunceli K, Yang JC, Gantz I, Brodovicz KG, Alexander CM, Davies MJ, Radican L. A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther 2015;6:75-84. [PMID: 25586555 DOI: 10.1007/s13300-015-0094-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
185 Casey DE Jr, Thomas RJ, Bhalla V, Commodore-Mensah Y, Heidenreich PA, Kolte D, Muntner P, Smith SC Jr, Spertus JA, Windle JR, Wozniak GD, Ziaeian B. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 2019;12:e000057. [PMID: 31714813 DOI: 10.1161/HCQ.0000000000000057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
186 DeLeon J, Silverstein BE, Allaire C, Gearinger LS, Bateman KM, Morris TW, Comstock TL. Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children. Clin Drug Investig 2012;32:303-17. [PMID: 22420526 DOI: 10.2165/11632470-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
187 Nevins TE, Robiner WN, Thomas W. Predictive patterns of early medication adherence in renal transplantation. Transplantation 2014;98:878-84. [PMID: 24831921 DOI: 10.1097/TP.0000000000000148] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
188 van Gils PF, Over EA, Hamberg-van Reenen HH, de Wit GA, van den Berg M, Schuit AJ, Engelfriet PM. The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open 2011;1:e000363. [PMID: 22189351 DOI: 10.1136/bmjopen-2011-000363] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
189 Mentias A, Heller E, Vaughan Sarrazin M. Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy. Stroke 2020;51:2076-86. [PMID: 32517580 DOI: 10.1161/STROKEAHA.120.029541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
190 Martinez KA, Fagerlin A, Witteman HO, Holmberg C, Hawley ST. What Matters to Women When Making Decisions About Breast Cancer Chemoprevention? Patient 2016;9:149-59. [PMID: 26115846 DOI: 10.1007/s40271-015-0134-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
191 Keuerleber S, Sauermann R. [Polypharmacy--activities of the social insurance in Austria]. Wien Med Wochenschr 2016;166:173-8. [PMID: 26847442 DOI: 10.1007/s10354-016-0434-5] [Reference Citation Analysis]
192 Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag 2008;4:269-86. [PMID: 18728716 DOI: 10.2147/tcrm.s1458] [Cited by in Crossref: 342] [Cited by in F6Publishing: 220] [Article Influence: 34.2] [Reference Citation Analysis]
193 Scichilone N, Contino A, Figlioli GB, Paglino G, Bellia V. Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options. Patient Prefer Adherence 2010;4:17-23. [PMID: 20165595 DOI: 10.2147/ppa.s5627] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
194 Tremblay S, Alloway RR. Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. AAPS J 2017;19:1332-47. [PMID: 28717926 DOI: 10.1208/s12248-017-0119-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Kooij JJ, Rösler M, Philipsen A, Wächter S, Dejonckheere J, van der Kolk A, van Agthoven M, Schäuble B. Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial. BMC Psychiatry 2013;13:36. [PMID: 23347693 DOI: 10.1186/1471-244X-13-36] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
196 Dilla T, Valladares A, Lizán L, Sacristán JA. [Treatment adherence and persistence: causes, consequences and improvement strategies]. Aten Primaria 2009;41:342-8. [PMID: 19427071 DOI: 10.1016/j.aprim.2008.09.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
197 Yaligod V, Raj DG, Sharma AB, Swami B M, Batra S, Acharya A, Maroo SH, Patel KR, Prajapati V. Dual release paracetamol in osteoarthritis of knee: a randomized controlled clinical trial. J Clin Diagn Res 2014;8:LC11-5. [PMID: 25584252 DOI: 10.7860/JCDR/2014/10052.5197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
198 van Boven JF, Kocks JW, Postma MJ. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands. Int J Chron Obstruct Pulmon Dis 2016;11:2191-201. [PMID: 27703341 DOI: 10.2147/COPD.S114738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
199 García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013;4:175-94. [PMID: 23990497 DOI: 10.1007/s13300-013-0034-y] [Cited by in Crossref: 317] [Cited by in F6Publishing: 238] [Article Influence: 39.6] [Reference Citation Analysis]
200 Calabria S, Cinconze E, Rossini M, Rossi E, Maggioni AP, Pedrini A, De Rosa M. Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. Patient Prefer Adherence 2016;10:523-30. [PMID: 27143860 DOI: 10.2147/PPA.S95634] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
201 Hughes D. Less is more: medicines that require less frequent administration improve adherence, but are they better? Pharmacoeconomics 2006;24:211-3. [PMID: 16519543 DOI: 10.2165/00019053-200624030-00001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
202 Bauer R, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Murray G, Ritter P, Lewitzka U. Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity. Int J Bipolar Disord. 2013;1:26. [PMID: 25505689 DOI: 10.1186/2194-7511-1-26] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
203 Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB; American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018;72:e53-e90. [PMID: 30354828 DOI: 10.1161/hyp.0000000000000084] [Cited by in Crossref: 238] [Cited by in F6Publishing: 68] [Article Influence: 119.0] [Reference Citation Analysis]
204 Nensa F, Tezgah E, Schweins K, Goebel J, Heusch P, Nassenstein K, Schlosser T, Poeppel TD. Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging. J Nucl Cardiol 2017;24:980-8. [PMID: 26993494 DOI: 10.1007/s12350-016-0443-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
205 Vouri SM, Jiang X, Manini TM, Solberg LM, Pepine C, Malone DC, Winterstein AG. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics. JAMA Netw Open 2019;2:e1918425. [PMID: 31880802 DOI: 10.1001/jamanetworkopen.2019.18425] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
206 Susanna R Jr, De Moraes CG, Cioffi GA, Ritch R. Why Do People (Still) Go Blind from Glaucoma? Transl Vis Sci Technol 2015;4:1. [PMID: 25767744 DOI: 10.1167/tvst.4.2.1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
207 Chin PK, Vella-Brincat JW, Barclay ML, Begg EJ. Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles? Br J Clin Pharmacol 2012;74:734-40. [PMID: 22432888 DOI: 10.1111/j.1365-2125.2012.04266.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
208 Iijima T, Aoki K, Kondo Y, Terauchi Y. Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial. J Clin Med Res 2020;12:73-8. [PMID: 32095176 DOI: 10.14740/jocmr4084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
209 Nguyen P, Nava-Ocampo A, Levy A, O'Connor DL, Einarson TR, Taddio A, Koren G. Effect of iron content on the tolerability of prenatal multivitamins in pregnancy. BMC Pregnancy Childbirth 2008;8:17. [PMID: 18482454 DOI: 10.1186/1471-2393-8-17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
210 Graham K, Sinyangwe C, Nicholas S, King R, Mukupa S, Källander K, Counihan H, Montague M, Tibenderana J, Hamade P. Rational use of antibiotics by community health workers and caregivers for children with suspected pneumonia in Zambia: a cross-sectional mixed methods study. BMC Public Health 2016;16:897. [PMID: 27567604 DOI: 10.1186/s12889-016-3541-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
211 Oonk NGM, Movig KLL, Munster EM, Koehorst-Ter Huurne K, van der Palen J, Dorresteijn LDA. The effect of a structured medication review on quality of life in Parkinson's disease: The study protocol. Contemp Clin Trials Commun 2019;13:100308. [PMID: 30582067 DOI: 10.1016/j.conctc.2018.100308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 Kemner JE, Lage MJ. Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis. Ann Gen Psychiatry 2006;5:5. [PMID: 16606463 DOI: 10.1186/1744-859X-5-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
213 Hurt RT, Mundi MS, Ebbert JO. Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release. Diabetes Metab Syndr Obes 2018;11:469-78. [PMID: 30233224 DOI: 10.2147/DMSO.S126855] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
214 Ali MA, Yasir J, Sherwani RN, Fareed M, Arshad F, Abid F, Arshad R, Ismail S, Khan SA, Siddiqui U, Muhammad MG, Fatima K. Frequency and predictors of non-adherence to lifestyle modifications and medications after coronary artery bypass grafting: A cross-sectional study. Indian Heart J 2017;69:469-73. [PMID: 28822513 DOI: 10.1016/j.ihj.2017.05.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
215 Aljoundi A, Bjij I, El Rashedy A, Soliman MES. Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective. Protein J 2020;39:97-105. [PMID: 32072438 DOI: 10.1007/s10930-020-09884-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
216 Arlt S, Lindner R, Rösler A, von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008;25:1033-47. [PMID: 19021302 DOI: 10.2165/0002512-200825120-00005] [Cited by in Crossref: 149] [Cited by in F6Publishing: 106] [Article Influence: 12.4] [Reference Citation Analysis]
217 Izquierdo JL, Paredero JM, Piedra R. Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016;11:289-93. [PMID: 26929614 DOI: 10.2147/COPD.S96948] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
218 Persu A, Jin Y, Fadl Elmula FE, Jacobs L, Renkin J, Kjeldsen S. Renal denervation after Symplicity HTN-3: an update. Curr Hypertens Rep 2014;16:460. [PMID: 24913923 DOI: 10.1007/s11906-014-0460-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
219 Oura K, Itabashi R, Omoto T, Yamaguchi Oura M, Kiyokawa T, Hirai E, Maeda T. Impact of Introducing the Pletaal Assist System on Drug Adherence in Outpatients with Ischaemic Stroke: A Pilot Study. Patient Prefer Adherence 2021;15:835-41. [PMID: 33907385 DOI: 10.2147/PPA.S297045] [Reference Citation Analysis]
220 Chesnut CH. Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate. Drugs 2006;66:1351-9. [PMID: 16903769 DOI: 10.2165/00003495-200666100-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
221 van Mierlo T, Fournier R, Ingham M. Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLoS One 2015;10:e0129364. [PMID: 26107637 DOI: 10.1371/journal.pone.0129364] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
222 Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007;14:25-9. [PMID: 17315055 DOI: 10.1155/2007/161652] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
223 Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y. Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1673-83. [PMID: 26316741 DOI: 10.2147/COPD.S86002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
224 Vaag A, Lund SS. Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues. Eur J Endocrinol 2012;166:159-70. [PMID: 21930715 DOI: 10.1530/EJE-11-0022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
225 Harris SC, Cipriano A, Colucci SV, Kapil RP, Geoffroy P, Hopyan T, Levy-Cooperman N. Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users. Pain Med 2017;18:1278-91. [PMID: 27651514 DOI: 10.1093/pm/pnw208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
226 MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:231-255. [PMID: 15813656 DOI: 10.2165/00002512-200522030-00005] [Cited by in Crossref: 206] [Cited by in F6Publishing: 140] [Article Influence: 12.9] [Reference Citation Analysis]
227 Patil AJ, Sharma A, Kenney MC, Kuppermann BD. Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients. Clin Ophthalmol 2010;4:111-9. [PMID: 20234777 DOI: 10.2147/opth.s3248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
228 Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug Des Devel Ther. 2013;7:1253-1258. [PMID: 24174870 DOI: 10.2147/dddt.s52820] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
229 Dasso L, Al-Khaled T, Sonty S, Aref AA. Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date. Clin Ophthalmol 2018;12:1939-44. [PMID: 30323550 DOI: 10.2147/OPTH.S154001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
230 Gordon EJ, Gallant M, Sehgal AR, Conti D, Siminoff LA. Medication-taking among adult renal transplant recipients: barriers and strategies. Transpl Int. 2009;22:534-545. [PMID: 19175560 DOI: 10.1111/j.1432-2277.2008.00827.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
231 Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence 2011;5:441-63. [PMID: 22003282 DOI: 10.2147/PPA.S23780] [Cited by in Crossref: 82] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
232 Hameed MA, Dasgupta I. Medication adherence and treatment-resistant hypertension: a review. Drugs Context 2019;8:212560. [PMID: 30774692 DOI: 10.7573/dic.212560] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
233 Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. CNS Drugs 2014;28:699-712. [PMID: 24794101 DOI: 10.1007/s40263-014-0169-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
234 Khalifa N, El-Husseini T, Morrah A, Mostafa E, Hamoud H. Use of ibuprofen sustained release for treating osteoarthritic pain: findings from 15 general medical practices in Egypt. Open Access Rheumatol 2014;6:49-56. [PMID: 27790034 DOI: 10.2147/OARRR.S59564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
235 Siederer S, Allen A, Yang S. Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease. Eur J Drug Metab Pharmacokinet 2016;41:743-58. [PMID: 26474864 DOI: 10.1007/s13318-015-0303-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
236 Liu HH. Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumonia. Curr Ther Res Clin Exp 2004;65:225-38. [PMID: 24764589 DOI: 10.1016/S0011-393X(04)80047-X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
237 Perucca E. Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilepsy Curr 2009;9:153-7. [PMID: 19936129 DOI: 10.1111/j.1535-7511.2009.01326.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
238 Furst DE, Shaikh SA, Greenwald M, Bennett B, Davies O, Luijtens K, Staelens F, Koetse W, Bertin P. Two dosing regimens of certolizumab pegol in patients with active rheumatoid arthritis. Arthritis Care Res (Hoboken) 2015;67:151-60. [PMID: 25302624 DOI: 10.1002/acr.22496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
239 Anyaike C, Atoyebi OA, Musa OI, Bolarinwa OA, Durowade KA, Ogundiran A, Babatunde OA. Adherence to combined Antiretroviral therapy (cART) among people living with HIV/AIDS in a Tertiary Hospital in Ilorin, Nigeria. Pan Afr Med J 2019;32:10. [PMID: 31080546 DOI: 10.11604/pamj.2019.32.10.7508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Sanguinetti CM, De Benedetto F, Donner CF, Nardini S, Visconti A. Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med 2014;9:35. [PMID: 24944787 DOI: 10.1186/2049-6958-9-35] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
241 Ribeiro M, Chapman KR. Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2012;7:145-52. [PMID: 22419862 DOI: 10.2147/COPD.S19805] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
242 Nalamachu S, Rauck RL, Hale ME, Florete OG Jr, Robinson CY, Farr SJ. A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain. J Pain Res 2014;7:669-78. [PMID: 25473308 DOI: 10.2147/JPR.S71536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
243 Cooper A, Drake J, Brankin E; PERSIST Investigators. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Pract 2006;60:896-905. [PMID: 16800837 DOI: 10.1111/j.1742-1241.2006.01059.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 75] [Article Influence: 7.0] [Reference Citation Analysis]
244 Grunberger G, Sze D, Ermakova A, Sieradzan R, Oliveria T, Miller EM. Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States. Clin Diabetes 2020;38:47-55. [PMID: 31975751 DOI: 10.2337/cd19-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
245 Grosset KA, Grosset DG. Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial. BMC Neurol 2007;7:20. [PMID: 17634109 DOI: 10.1186/1471-2377-7-20] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
246 Assari S, Helmi H, Bazargan M. Polypharmacy in African American Adults: A National Epidemiological Study. Pharmacy (Basel) 2019;7:E33. [PMID: 30934828 DOI: 10.3390/pharmacy7020033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
247 Frishman WH, Henderson LS, Lukas MA. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction. Vasc Health Risk Manag 2008;4:1387-400. [PMID: 19337551 DOI: 10.2147/vhrm.s3148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
248 Milgrom H. Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence. Paediatr Drugs 2010;12:213-21. [PMID: 20593906 DOI: 10.2165/11316220-000000000-00000] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
249 Asakura T, Jensen KH. Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol 2009;3:312-9. [PMID: 20144362 DOI: 10.1177/193229680900300212] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
250 Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei GC, Casati M, Franchi C, Djade CD, Nobili A. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging 2014;31:283-9. [PMID: 24604085 DOI: 10.1007/s40266-014-0163-7] [Cited by in Crossref: 116] [Cited by in F6Publishing: 75] [Article Influence: 16.6] [Reference Citation Analysis]
251 Swarna Nantha Y, Haque S, Swarna Nantha H. The development of an integrated behavioural model of patient compliance with diabetes medication: a mixed-method study protocol. Fam Pract 2019;36:581-6. [PMID: 30534941 DOI: 10.1093/fampra/cmy119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
252 Horii T, Momo K, Yasu T, Kabeya Y, Atsuda K. Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. PLoS One 2019;14:e0223431. [PMID: 31593574 DOI: 10.1371/journal.pone.0223431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
253 Bakerly ND, Woodcock A, New JP, Gibson JM, Wu W, Leather D, Vestbo J. The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease. Respir Res 2015;16:101. [PMID: 26337978 DOI: 10.1186/s12931-015-0267-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
254 Kang SH, Kim SH, Cho JH, Yoon CH, Hwang SS, Lee HY, Youn TJ, Chae IH, Kim CH. Prevalence, Awareness, Treatment, and Control of Hypertension in Korea. Sci Rep 2019;9:10970. [PMID: 31358791 DOI: 10.1038/s41598-019-46965-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
255 Salas M, Kiefe CI, Schreiner PJ, Kim Y, Juarez L, Person SD, Williams OD. Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study. Patient 2008;1:41-54. [PMID: 22272756 DOI: 10.2165/01312067-200801010-00007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
256 Moreira RO, Cobas R, Lopes Assis Coelho RC. Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes? Diabetol Metab Syndr 2018;10:26. [PMID: 29636825 DOI: 10.1186/s13098-018-0327-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
257 Di Prima G, Campisi G, De Caro V. Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness. J Pers Med 2020;10:E242. [PMID: 33255761 DOI: 10.3390/jpm10040242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
258 Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health 2010;10:651. [PMID: 21029405 DOI: 10.1186/1471-2458-10-651] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 7.5] [Reference Citation Analysis]
259 Kaiser EA, Lotze U, Schäfer HH. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging 2014;9:459-75. [PMID: 24711696 DOI: 10.2147/CIA.S40154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
260 Scheidel B, Maritz MA, Gschwind YJ, Steigerwald K, Guth V, Kovacs P, Rey H. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
. Int J Clin Pharmacol Ther 2017;55:881-90. [PMID: 28933336 DOI: 10.5414/CP203005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
261 Gaber AO, Alloway RR, Bodziak K, Kaplan B, Bunnapradist S. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. Transplantation. 2013;96:191-197. [PMID: 23715050 DOI: 10.1097/tp.0b013e3182962cc1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 14] [Article Influence: 6.9] [Reference Citation Analysis]
262 Bryant KB, Moran AE, Kazi DS, Zhang Y, Penko J, Ruiz-Negrón N, Coxson P, Blyler CA, Lynch K, Cohen LP, Tajeu GS, Fontil V, Moy NB, Ebinger JE, Rader F, Bibbins-Domingo K, Bellows BK. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops. Circulation 2021;143:2384-94. [PMID: 33855861 DOI: 10.1161/CIRCULATIONAHA.120.051683] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
263 Huskamp HA, Busch AB, Domino ME, Normand SL. Antidepressant reformulations: who uses them, and what are the benefits? Health Aff (Millwood) 2009;28:734-45. [PMID: 19414882 DOI: 10.1377/hlthaff.28.3.734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
264 McGill JB. Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence. Vasc Health Risk Manag 2010;6:363-72. [PMID: 20539838 DOI: 10.2147/vhrm.s6668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
265 Ramli A, Aljunid SM, Sulong S, Md Yusof FA. National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool. Ther Clin Risk Manag 2013;9:491-504. [PMID: 24353428 DOI: 10.2147/TCRM.S52078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
266 Dohar J, Cantón R, Cohen R, Farrell DJ, Felmingham D. Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis. Ann Clin Microbiol Antimicrob 2004;3:15. [PMID: 15287988 DOI: 10.1186/1476-0711-3-15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
267 Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007;3:117-31. [PMID: 19300542 DOI: 10.2147/nedt.2007.3.1.117] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
268 Weiss TW, McHorney CA. Osteoporosis medication profile preference: results from the PREFER-US study. Health Expect 2007;10:211-23. [PMID: 17678510 DOI: 10.1111/j.1369-7625.2007.00440.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
269 Chapman RH, Pelletier EM, Smith PJ, Roberts CS. Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? Patient Prefer Adherence 2009;3:265-75. [PMID: 19936170 DOI: 10.2147/ppa.s5868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
270 Cushing A, Manice MP, Ting A, Parides MK. Feasibility of a novel mHealth management system to capture and improve medication adherence among adolescents with asthma. Patient Prefer Adherence 2016;10:2271-5. [PMID: 27853357 DOI: 10.2147/PPA.S115713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
271 Petersen LA, Woodard LD, Henderson LM, Urech TH, Pietz K. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients? Circulation 2009;119:2978-85. [PMID: 19487595 DOI: 10.1161/CIRCULATIONAHA.108.836544] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
272 Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009;10:45. [PMID: 19493329 DOI: 10.1186/1465-9921-10-45] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 8.0] [Reference Citation Analysis]
273 Seoane-Vazquez E, Rodriguez-Monguio R, Hansen R. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs. Clin Drug Investig 2016;36:281-92. [PMID: 26818406 DOI: 10.1007/s40261-015-0374-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
274 Navaratnam P, Friedman HS, Urdaneta E. The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents. Patient Prefer Adherence 2010;4:197-205. [PMID: 20622918 DOI: 10.2147/ppa.s9800] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
275 Kalra S, Aamir AH, Raza A, Das AK, Azad Khan AK, Shrestha D, Qureshi MF, Md Fariduddin, Pathan MF, Jawad F, Bhattarai J, Tandon N, Somasundaram N, Katulanda P, Sahay R, Dhungel S, Bajaj S, Chowdhury S, Ghosh S, Madhu SV, Ahmed T, Bulughapitiya U, Qureshi MF, Md Fariduddin, Pathan MF, Jawad F. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. Indian J Endocrinol Metab. 2015;19:577-596. [PMID: 26425465 DOI: 10.4103/2230-8210.163171] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
276 Piana C, Zhao W, Adkison K, Burger D, Jacqz-Aigrain E, Danhof M, Della Pasqua O. A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children. Br J Clin Pharmacol 2014;77:852-60. [PMID: 24118047 DOI: 10.1111/bcp.12246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
277 Jabbour E, Saglio G, Radich J, Kantarjian H. Adherence to BCR-ABL inhibitors: issues for CML therapy. Clin Lymphoma Myeloma Leuk 2012;12:223-9. [PMID: 22633166 DOI: 10.1016/j.clml.2012.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
278 Comstock TL, Paterno MR, Usner DW, Pichichero ME. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials. Paediatr Drugs 2010;12:105-12. [PMID: 20218747 DOI: 10.2165/11534380-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
279 Bazargan M, Smith J, Saqib M, Helmi H, Assari S. Associations between Polypharmacy, Self-Rated Health, and Depression in African American Older Adults; Mediators and Moderators. Int J Environ Res Public Health 2019;16:E1574. [PMID: 31064059 DOI: 10.3390/ijerph16091574] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
280 Stange D, Kriston L, von Wolff A, Baehr M, Dartsch DC. Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care. Eur J Clin Pharmacol 2013;69:573-80. [PMID: 22828657 DOI: 10.1007/s00228-012-1342-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
281 Ashton AK, Jamerson BD, L Weinstein W, Wagoner C. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey. Curr Ther Res Clin Exp 2005;66:96-106. [PMID: 24672116 DOI: 10.1016/j.curtheres.2005.04.006] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 9.7] [Reference Citation Analysis]
282 Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res 2010;4:11-24. [PMID: 21386951 DOI: 10.2147/JPR.S9492] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
283 Kiran A, Viscoli CM, Furie KL, Gorman M, Kernan WN. Adherence to study drug in a stroke prevention trial"?>. J Stroke Cerebrovasc Dis 2020;29:105048. [PMID: 32912514 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105048] [Reference Citation Analysis]
284 Lavan RP, Tunceli K, Zhang D, Normile D, Armstrong R. Assessment of dog owner adherence to veterinarians' flea and tick prevention recommendations in the United States using a cross-sectional survey. Parasit Vectors 2017;10:284. [PMID: 28583186 DOI: 10.1186/s13071-017-2217-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
285 Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K; MELT investigators. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplant 2013;13:760-9. [PMID: 23279614 DOI: 10.1111/ajt.12035] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
286 Bosman J, Ter Horst PG, Smit JP, Dijkstra JR, Beekhuis HR, Slingersland RJ, Hospes W. Adherence of antidepressants during pregnancy: MEMS compared with three other methods. Ther Adv Psychopharmacol 2014;4:61-9. [PMID: 24688757 DOI: 10.1177/2045125313511486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
287 Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review. Drugs Aging 2017;34:97-113. [PMID: 28025725 DOI: 10.1007/s40266-016-0426-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
288 Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL, Christiansen C, Rowell L, Mairon N, Bonvoisin B, Drezner MK, Emkey R, Felsenberg D, Cooper C, Delmas PD, Miller PD. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis 2006;65:654-61. [PMID: 16339289 DOI: 10.1136/ard.2005.044958] [Cited by in Crossref: 219] [Cited by in F6Publishing: 148] [Article Influence: 13.7] [Reference Citation Analysis]
289 Mancia G, Grassi G. Individualization of antihypertensive drug treatment. Diabetes Care 2013;36 Suppl 2:S301-6. [PMID: 23882063 DOI: 10.2337/dcS13-2013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
290 DuBay DA, Teperman L, Ueda K, Silverman A, Chapman W, Alsina AE, Tyler C, Stevens DR. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant. Clin Pharmacol Drug Dev. 2019;8:995-1008. [PMID: 30667591 DOI: 10.1002/cpdd.657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
291 Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 2008;9:2. [PMID: 18237373 DOI: 10.1186/1471-2369-9-2] [Cited by in Crossref: 150] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
292 Schlander M. Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness. Eur Child Adolesc Psychiatry 2007;16:421-9. [PMID: 17401606 DOI: 10.1007/s00787-007-0615-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
293 Darbà J, Ramírez G, Sicras A, García-Bujalance L, Torvinen S, Sánchez-de la Rosa R. Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence 2016;10:135-45. [PMID: 26929605 DOI: 10.2147/PPA.S95303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
294 Mancia G, Coca A, Chazova I, Girerd X, Haller H, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT investigators. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens 2014;32:1700-7; discussion 1707. [PMID: 24906174 DOI: 10.1097/HJH.0000000000000239] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
295 Dorman RM, Yee LM, Sutton SH. Pill aversion in HIV-infected pregnant women: Theory to practice. J Perinatol 2017;37:215-9. [PMID: 27735932 DOI: 10.1038/jp.2016.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
296 Mura P, Maestrelli F, D'Ambrosio M, Luceri C, Cirri M. Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations. Pharmaceutics 2021;13:437. [PMID: 33804945 DOI: 10.3390/pharmaceutics13040437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
297 Liu X, Chen Y, Faries DE. Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder. Clinicoecon Outcomes Res 2011;3:63-72. [PMID: 21935334 DOI: 10.2147/CEOR.S17846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
298 Ewen S, Rettig-Ewen V, Mahfoud F, Böhm M, Laufs U. Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol 2014;103:173-82. [PMID: 23999974 DOI: 10.1007/s00392-013-0616-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
299 Sewerynek E, Horst-Sikorska H, Stępień-Kłos W, Antkowiak A, Janik M, Cieślak K, Marcinkowska M, Cegłowska A, Stuss M. The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy. Arch Med Sci 2013;9:288-96. [PMID: 23671440 DOI: 10.5114/aoms.2013.34575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
300 Prendergast MB, Gaston RS. Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5:1305-1311. [PMID: 20448067 DOI: 10.2215/cjn.07241009] [Cited by in Crossref: 100] [Cited by in F6Publishing: 30] [Article Influence: 9.1] [Reference Citation Analysis]
301 Clemens A, Noack H, Brueckmann M, Lip GY. Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria. PLoS One 2014;9:e99276. [PMID: 24911432 DOI: 10.1371/journal.pone.0099276] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
302 Babalonis S, Hampson AJ, Lofwall MR, Nuzzo PA, Walsh SL. Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans. J Clin Pharmacol 2015;55:1332-43. [PMID: 26032168 DOI: 10.1002/jcph.557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
303 Czajkowska Z, Wang H, Hall NC, Sewitch M, Körner A. Validation of the English and French versions of the Brief Health Care Climate Questionnaire. Health Psychol Open 2017;4:2055102917730675. [PMID: 29379621 DOI: 10.1177/2055102917730675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
304 Schneider F, Bradbury M, Baillie TA, Stamler D, Hellriegel E, Cox DS, Loupe PS, Savola JM, Rabinovich-Guilatt L. Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV-50717) Compared With Tetrabenazine in Healthy Volunteers. Clin Transl Sci 2020;13:707-17. [PMID: 32155315 DOI: 10.1111/cts.12754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
305 Patel K, Sudhir VS, Kabadi S, Huang JC, Porwal S, Thakkar K, Pagel JM. Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees. J Oncol Pharm Pract 2019;25:1897-906. [PMID: 30823852 DOI: 10.1177/1078155219827637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Zdzieblik D, Jendricke P, Oesser S, Gollhofer A, König D. The Influence of Specific Bioactive Collagen Peptides on Body Composition and Muscle Strength in Middle-Aged, Untrained Men: A Randomized Controlled Trial. Int J Environ Res Public Health 2021;18:4837. [PMID: 33946565 DOI: 10.3390/ijerph18094837] [Reference Citation Analysis]
307 Jacobsen JPR, Krystal AD, Krishnan KRR, Caron MG. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends Pharmacol Sci 2016;37:933-44. [PMID: 27692695 DOI: 10.1016/j.tips.2016.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
308 Viau KS, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA. Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep 2016;6:27-33. [PMID: 27014576 DOI: 10.1016/j.ymgmr.2016.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
309 Assari S, Bazargan M. Race/Ethnicity, Socioeconomic Status, and Polypharmacy among Older Americans. Pharmacy (Basel) 2019;7:E41. [PMID: 31027176 DOI: 10.3390/pharmacy7020041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
310 Runganga M, Peel NM, Hubbard RE. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study. Clin Interv Aging 2014;9:1453-62. [PMID: 25214773 DOI: 10.2147/CIA.S64105] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
311 Schousboe JT. Adherence with medications used to treat osteoporosis: behavioral insights. Curr Osteoporos Rep 2013;11:21-9. [PMID: 23334573 DOI: 10.1007/s11914-013-0133-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
312 Jamison J, Graffy J, Mullis R, Mant J, Sutton S. Stroke survivors', caregivers' and GPs' attitudes towards a polypill for the secondary prevention of stroke: a qualitative interview study. BMJ Open 2016;6:e010458. [PMID: 27178972 DOI: 10.1136/bmjopen-2015-010458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
313 Haluzík M, Fulcher G, Pieber TR, Bardtrum L, Tutkunkardas D, Rodbard HW. The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes. Diabetes Obes Metab 2018;20:1585-92. [PMID: 29451706 DOI: 10.1111/dom.13261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
314 Feldman G, Siler T, Prasad N, Jack D, Piggott S, Owen R, Higgins M, Kramer B; INLIGHT 1 study group. Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulm Med 2010;10:11. [PMID: 20211002 DOI: 10.1186/1471-2466-10-11] [Cited by in Crossref: 75] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
315 Lee S, Glendenning P, Inderjeeth CA. Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. Osteoporos Int 2011;22:741-53. [PMID: 20589368 DOI: 10.1007/s00198-010-1335-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
316 Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675-682. [PMID: 23874088 DOI: 10.2147/ppa.s29549] [Cited by in Crossref: 162] [Cited by in F6Publishing: 71] [Article Influence: 20.3] [Reference Citation Analysis]
317 Toh MR, Teo V, Kwan YH, Raaj S, Tan SY, Tan JZ. Association between number of doses per day, number of medications and patient's non-compliance, and frequency of readmissions in a multi-ethnic Asian population. Prev Med Rep 2014;1:43-7. [PMID: 26844038 DOI: 10.1016/j.pmedr.2014.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
318 Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, Flanagan T, Tuleu C. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs 2014;74:1871-89. [PMID: 25274536 DOI: 10.1007/s40265-014-0297-2] [Cited by in Crossref: 112] [Cited by in F6Publishing: 81] [Article Influence: 18.7] [Reference Citation Analysis]
319 Silveira Seixas RC, Balbino M, Basile Neto A, de Alcantara Almeida Costa A, Jordão MLDS, Russ HHA. Mid-Term Evaluation of iStent Inject® Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: A Retrospective Study. Clin Ophthalmol 2020;14:4403-13. [PMID: 33364745 DOI: 10.2147/OPTH.S283587] [Reference Citation Analysis]
320 Souliotis K, Peppou LE, Economou M, Marioli A, Nikolaidi S, Saridi M, Varvaras D, Paschali A, Syrigos KN. Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians. Asian Pac J Cancer Prev 2021;22:1891-8. [PMID: 34181348 DOI: 10.31557/APJCP.2021.22.6.1891] [Reference Citation Analysis]
321 Nawarskas JJ, Snowden SS. Critical appraisal of ticagrelor in the management of acute coronary syndrome. Ther Clin Risk Manag 2011;7:473-88. [PMID: 22241944 DOI: 10.2147/TCRM.S19835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
322 Mastromarino V, Casenghi M, Testa M, Gabriele E, Coluccia R, Rubattu S, Volpe M. Polypharmacy in heart failure patients. Curr Heart Fail Rep 2014;11:212-9. [PMID: 24493574 DOI: 10.1007/s11897-014-0186-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
323 Farlow MR, Somogyi M. Transdermal patches for the treatment of neurologic conditions in elderly patients: a review. Prim Care Companion CNS Disord 2011;13:PCC. [PMID: 22454804 DOI: 10.4088/PCC.11r01149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
324 Wang HS, Oh BS, Wang B, Ruan Y, Zhou J, Banie L, Lee YC, Tamaddon A, Zhou T, Wang G, Lin G, Lue TF. Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats. BJU Int 2018;122:490-500. [PMID: 29603534 DOI: 10.1111/bju.14216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
325 Scichilone N, Benfante A, Morandi L, Bellini F, Papi A. Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Relat Outcome Meas 2014;5:153-62. [PMID: 25473323 DOI: 10.2147/PROM.S55276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 0.1] [Reference Citation Analysis]
326 van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007;7:55. [PMID: 17439645 DOI: 10.1186/1472-6963-7-55] [Cited by in Crossref: 324] [Cited by in F6Publishing: 224] [Article Influence: 23.1] [Reference Citation Analysis]
327 Alexa T, Lavinia A, Luca A, Miron L, Alexa ID. Incidence of chemotherapy discontinuation and characteristics of elderly patients with non-small cell lung cancer treated with platinum-based doublets. Contemp Oncol (Pozn) 2014;18:340-3. [PMID: 25477757 DOI: 10.5114/wo.2014.45293] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
328 Gerhard T, Delaney JA, Cooper-Dehoff RM, Shuster J, Brumback BA, Johnson JA, Pepine CJ, Winterstein AG. Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. BMC Med Res Methodol 2012;12:119. [PMID: 22866767 DOI: 10.1186/1471-2288-12-119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
329 Smelt HJM, Pouwels S, Smulders JF, Hazebroek EJ. Patient adherence to multivitamin supplementation after bariatric surgery: a narrative review. J Nutr Sci 2020;9:e46. [PMID: 33101663 DOI: 10.1017/jns.2020.41] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
330 Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient Prefer Adherence 2016;10:2117-25. [PMID: 27799748 DOI: 10.2147/PPA.S118121] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
331 Nakajima H, Okada S, Mohri T, Kanda E, Inaba N, Hirasawa Y, Seino H, Kuroda H, Hiyoshi T, Niiya T, Ishii H. Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). Diabetol Metab Syndr 2018;10:11. [PMID: 29507611 DOI: 10.1186/s13098-018-0313-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
332 Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003) 2013;53:172-81. [PMID: 23571625 DOI: 10.1331/JAPhA.2013.12202] [Cited by in Crossref: 259] [Cited by in F6Publishing: 91] [Article Influence: 37.0] [Reference Citation Analysis]
333 Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, Ajiro Y, Haruta S, Yamada Y, Sawada E, Hagiwara N; SMAAP‐AF investigators. Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial. J Arrhythm 2021;37:616-25. [PMID: 34141014 DOI: 10.1002/joa3.12532] [Reference Citation Analysis]
334 van Mierlo T, Li X, Hyatt D, Ching AT. Demographic and Indication-Specific Characteristics Have Limited Association With Social Network Engagement: Evidence From 24,954 Members of Four Health Care Support Groups. J Med Internet Res 2017;19:e40. [PMID: 28213340 DOI: 10.2196/jmir.6330] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
335 Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011;9:11-23. [PMID: 21459305 DOI: 10.1016/j.amjopharm.2011.02.004] [Cited by in Crossref: 325] [Cited by in F6Publishing: 231] [Article Influence: 36.1] [Reference Citation Analysis]
336 Cazzola M, Matera MG. Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol 2008;155:291-9. [PMID: 18604231 DOI: 10.1038/bjp.2008.284] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
337 Feher MD, Brazier J, Schaper N, Vega-Hernandez G, Nikolajsen A, Bøgelund M. Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes. BMJ Open Diabetes Res Care 2016;4:e000192. [PMID: 27158518 DOI: 10.1136/bmjdrc-2016-000192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
338 von Alvensleben JC, LaPage MJ, Caruthers R, Bradley DJ. Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children. Pediatr Cardiol 2017;38:525-30. [PMID: 27995288 DOI: 10.1007/s00246-016-1544-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
339 Lewanczuk R, Tobe SW. More medications, fewer pills: combination medications for the treatment of hypertension. Can J Cardiol 2007;23:573-6. [PMID: 17534465 DOI: 10.1016/s0828-282x(07)70803-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
340 Devine J, Trice S, Finney Z, Yarger S, Nwokeji E, Linton A, Davies W. A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US Military Health System. Osteoporos Int 2012;23:1415-24. [PMID: 21786005 DOI: 10.1007/s00198-011-1729-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
341 Congpuong K, Bualombai P, Banmairuroi V, Na-Bangchang K. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Malar J 2010;9:43. [PMID: 20132537 DOI: 10.1186/1475-2875-9-43] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
342 Cacoub P, Ouzan D, Melin P, Lang JP, Rotily M, Fontanges T, Varastet M, Chousterman M, Marcellin P. Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational study. World J Gastroenterol 2008;14:6195-203. [PMID: 18985810 DOI: 10.3748/wjg.14.6195] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
343 Fried TR, Niehoff K, Tjia J, Redeker N, Goldstein MK. A Delphi process to address medication appropriateness for older persons with multiple chronic conditions. BMC Geriatr 2016;16:67. [PMID: 26979576 DOI: 10.1186/s12877-016-0240-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
344 Jo HE, Randhawa S, Corte TJ, Moodley Y. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs Aging 2016;33:321-34. [PMID: 27083934 DOI: 10.1007/s40266-016-0366-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
345 Sergi G, De Rui M, Sarti S, Manzato E. Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use? Drugs Aging. 2011;28:509-518. [PMID: 21721596 DOI: 10.2165/11592010-000000000-00000] [Cited by in Crossref: 102] [Cited by in F6Publishing: 61] [Article Influence: 11.3] [Reference Citation Analysis]
346 Corsale I, Carrieri P, Martellucci J, Piccolomini A, Verre L, Rigutini M, Panicucci S. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study. Int J Colorectal Dis. 2018;33:1595-1600. [PMID: 29934701 DOI: 10.1007/s00384-018-3102-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
347 Fletcher CV. Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count. Drugs 2007;67:1969-79. [PMID: 17883282 DOI: 10.2165/00003495-200767140-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
348 Lage MJ, Hassan MK. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Ann Gen Psychiatry. 2009;8:7. [PMID: 19226463 DOI: 10.1186/1744-859x-8-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
349 Rossi AP, Facchinetti R, Ferrari E, Nori N, Sant S, Masciocchi E, Zoico E, Fantin F, Mazzali G, Zamboni M. Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation. J Thromb Thrombolysis 2018;46:139-44. [PMID: 29761426 DOI: 10.1007/s11239-018-1679-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
350 Morgan C, McBeth J, Cordingley L, Watson K, Hyrich KL, Symmons DP, Bruce IN. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology (Oxford) 2015;54:1780-91. [PMID: 25972390 DOI: 10.1093/rheumatology/kev105] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
351 Oyekan E, Nimalasuriya A, Martin J, Scott R, Dudl RJ, Green K. The B-SMART Appropriate Medication-Use Process: A Guide for Clinicians to Help Patients- Part 1: Barriers, Solutions, and Motivation. Perm J 2009;13:62-9. [PMID: 21373248 DOI: 10.7812/tpp/07-057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Bleecker ER, Siler T, Owen R, Kramer B. Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data. Int J Chron Obstruct Pulmon Dis 2011;6:431-8. [PMID: 22003288 DOI: 10.2147/COPD.S21073] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
353 Ankrah DN, Koster ES, Mantel-Teeuwisse AK, Arhinful DK, Agyepong IA, Lartey M. Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adherence 2016;10:329-37. [PMID: 27042024 DOI: 10.2147/PPA.S96691] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
354 Wu JR, Lennie TA, De Jong MJ, Frazier SK, Heo S, Chung ML, Moser DK. Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure. J Card Fail 2010;16:142-9. [PMID: 20142026 DOI: 10.1016/j.cardfail.2009.10.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
355 Zylstra B, Netscher G, Jacquemot J, Schaffer M, Shen G, Bowhay AD, Braley TL, Possin KL, Miller BL, Bayen AM, Bonasera SJ, Schenk AK. Extended, continuous measures of functional status in community dwelling persons with Alzheimer's and related dementia: Infrastructure, performance, tradeoffs, preliminary data, and promise. J Neurosci Methods 2018;300:59-67. [PMID: 28865985 DOI: 10.1016/j.jneumeth.2017.08.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
356 Harris SC, Cipriano A, Colucci SV, Kapil RP, Geoffroy P, Hopyan T, Levy-Cooperman N. Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users. Pain Med 2016;17:820-31. [PMID: 26814240 DOI: 10.1093/pm/pnv004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
357 Furfine ES, Baker CT, Hale MR, Reynolds DJ, Salisbury JA, Searle AD, Studenberg SD, Todd D, Tung RD, Spaltenstein A. Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir. Antimicrob Agents Chemother 2004;48:791-8. [PMID: 14982766 DOI: 10.1128/AAC.48.3.791-798.2004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
358 Peng A, Kosloski MP, Nakamura G, Ding H, Balu-Iyer SV. PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice. AAPS J 2012;14:35-42. [PMID: 22173945 DOI: 10.1208/s12248-011-9309-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
359 Kenning C, Protheroe J, Gray N, Ashcroft D, Bower P. The potential for using a Universal Medication Schedule (UMS) to improve adherence in patients taking multiple medications in the UK: a qualitative evaluation. BMC Health Serv Res 2015;15:94. [PMID: 25888725 DOI: 10.1186/s12913-015-0749-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
360 Bell SP, Saraf AA. Epidemiology of Multimorbidity in Older Adults with Cardiovascular Disease. Clin Geriatr Med 2016;32:215-26. [PMID: 27113142 DOI: 10.1016/j.cger.2016.01.013] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
361 Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas AG. Quality of Life in Glaucoma: A Review of the Literature. Adv Ther 2016;33:959-81. [PMID: 27138604 DOI: 10.1007/s12325-016-0333-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 45] [Article Influence: 14.2] [Reference Citation Analysis]
362 Hughes D. When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007;25:621-35. [PMID: 17640105 DOI: 10.2165/00019053-200725080-00001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
363 Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 2013;35:51-6. [PMID: 23054137 DOI: 10.1007/s11096-012-9704-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
364 Schlander M. The NICE ADHD health technology assessment: a review and critique. Child Adolesc Psychiatry Ment Health 2008;2:1. [PMID: 18197978 DOI: 10.1186/1753-2000-2-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
365 Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D; ACTG A5073 Study Team. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis 2010;50:1041-52. [PMID: 20192725 DOI: 10.1086/651118] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
366 Pilhatsch M, Glenn T, Rasgon N, Alda M, Sagduyu K, Grof P, Munoz R, Marsh W, Monteith S, Severus E, Bauer R, Ritter P, Whybrow PC, Bauer M. Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder. Int J Bipolar Disord 2018;6:10. [PMID: 29713845 DOI: 10.1186/s40345-018-0118-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
367 Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 2006;148:565-78. [PMID: 16751797 DOI: 10.1038/sj.bjp.0706780] [Cited by in Crossref: 368] [Cited by in F6Publishing: 245] [Article Influence: 24.5] [Reference Citation Analysis]
368 Chung SS, Fakhoury TA, Hogan RE, Nagaraddi VN, Blatt I, Lawson B, Arnold S, Anders B, Clark AM, Laine D, Meadows RS, Halvorsen MB; PREVAIL Study Group. Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study. Epilepsia 2014;55:1077-87. [PMID: 24902983 DOI: 10.1111/epi.12660] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
369 Pentikis HS, Adetoro N. Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions. Clin Pharmacol Drug Dev 2018;7:543-53. [PMID: 29125715 DOI: 10.1002/cpdd.406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
370 Sumarsono A, Sumarsono N, Das SR, Vaduganathan M, Agrawal D, Pandey A. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries. JAMA Netw Open 2020;3:e200181. [PMID: 32108893 DOI: 10.1001/jamanetworkopen.2020.0181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
371 Lee LK, Goren A, Boytsov NN, Donatucci CF, McVary KT. Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations. Patient Prefer Adherence 2016;10:1205-15. [PMID: 27471377 DOI: 10.2147/PPA.S105241] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
372 Giorgino F, Penfornis A, Pechtner V, Gentilella R, Corcos A. Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement. Patient Prefer Adherence 2018;12:707-19. [PMID: 29765207 DOI: 10.2147/PPA.S151736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
373 Magura S, Rosenblum A, Fong C. Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. Open Addict J 2011;4:58-64. [PMID: 23264842 DOI: 10.2174/1874941001104010058] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
374 Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 2016;10:1299-307. [PMID: 27524885 DOI: 10.2147/PPA.S106821] [Cited by in Crossref: 197] [Cited by in F6Publishing: 89] [Article Influence: 39.4] [Reference Citation Analysis]
375 Kim H, Lee YS, Kim TH, Cha MJ, Lee JM, Park J, Park JK, Kang KW, Shim J, Uhm JS, Park HW, Choi EK, Kim JB, Kim C, Kim J, Joung B. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF). Korean J Intern Med 2020;35:99-108. [PMID: 31014064 DOI: 10.3904/kjim.2017.415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
376 Schawo S, van der Kolk A, Bouwmans C, Annemans L, Postma M, Buitelaar J, van Agthoven M, Hakkaart-van Roijen L. Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed? Pharmacoeconomics 2015;33:489-509. [PMID: 25715975 DOI: 10.1007/s40273-015-0259-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
377 Schmitz JM, Sayre SL, Stotts AL, Rothfleisch J, Mooney ME. Medication compliance during a smoking cessation clinical trial: a brief intervention using MEMS feedback. J Behav Med 2005;28:139-47. [PMID: 15957569 DOI: 10.1007/s10865-005-3663-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
378 Hizawa N. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Int J Chron Obstruct Pulmon Dis 2015;10:1093-102. [PMID: 26089659 DOI: 10.2147/COPD.S72858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
379 Ritchey MD, Wall HK, George MG, Wright JS. US trends in premature heart disease mortality over the past 50 years: Where do we go from here? Trends Cardiovasc Med 2020;30:364-74. [PMID: 31607635 DOI: 10.1016/j.tcm.2019.09.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
380 Westropp JL, Sykes JE, Irom S, Daniels JB, Smith A, Keil D, Settje T, Wang Y, Chew DJ. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. J Vet Intern Med 2012;26:506-12. [PMID: 22486931 DOI: 10.1111/j.1939-1676.2012.00914.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
381 Ailinger RL, Black PL, Lima-Garcia N. Use of electronic monitoring in clinical nursing research. Clin Nurs Res 2008;17:89-97. [PMID: 18387881 DOI: 10.1177/1054773808316941] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
382 Ananthakrishnan AN, Donaldson T, Lasch K, Yajnik V. Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities. Inflamm Bowel Dis. 2017;23:882-893. [PMID: 28375885 DOI: 10.1097/mib.0000000000001099] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 10.7] [Reference Citation Analysis]
383 Abbasinazari M, Sahraee Z, Mirahmadi M. The Patients' Adherence and Adverse Drug Reactions (ADRs) which are Caused by Helicobacter pylori Eradication Regimens. J Clin Diagn Res 2013;7:462-6. [PMID: 23634397 DOI: 10.7860/JCDR/2013/4673.2799] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
384 Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010;28:1097-107. [PMID: 21080735 DOI: 10.2165/11537400-000000000-00000] [Cited by in Crossref: 131] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
385 Casey DE Jr, Thomas RJ, Bhalla V, Commodore-Mensah Y, Heidenreich PA, Kolte D, Muntner P, Smith SC Jr, Spertus JA, Windle JR, Wozniak GD, Ziaeian B. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 2019;74:2661-706. [PMID: 31732293 DOI: 10.1016/j.jacc.2019.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
386 Al-Barrak J, Cheung WY. Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia. Support Care Cancer 2013;21:2351-7. [PMID: 23708821 DOI: 10.1007/s00520-013-1831-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
387 Morrison A, Stauffer ME, Kaufman AS. Relationship Between Adherence Rate Threshold and Drug 'Forgiveness'. Clin Pharmacokinet 2017;56:1435-40. [PMID: 28470545 DOI: 10.1007/s40262-017-0552-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
388 Srivastava K, Arora A, Kataria A, Cappelleri JC, Sadosky A, Peterson AM. Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence 2013;7:419-34. [PMID: 23737662 DOI: 10.2147/PPA.S44646] [Cited by in Crossref: 8] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
389 Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs 2003;17:117-31. [PMID: 12521359 DOI: 10.2165/00023210-200317020-00004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 5.9] [Reference Citation Analysis]
390 van Bodegraven AA, Mulder CJ. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol 2006;12:6115-23. [PMID: 17036381 DOI: 10.3748/wjg.v12.i38.6115] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
391 Calkwood J, Cree B, Crayton H, Kantor D, Steingo B, Barbato L, Hashmonay R, Agashivala N, McCague K, Tenenbaum N, Edwards K. Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial. BMC Neurol 2014;14:220. [PMID: 25424122 DOI: 10.1186/s12883-014-0220-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
392 Kim YC, Edelhauser HF, Prausnitz MR. Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles. Invest Ophthalmol Vis Sci 2014;55:7387-97. [PMID: 25212782 DOI: 10.1167/iovs.14-14651] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
393 Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication adherence and persistence in severe obstructive sleep apnea. Sleep 2009;32:623-8. [PMID: 19480229 DOI: 10.1093/sleep/32.5.623] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
394 Hughes DA, Bagust A, Haycox A, Walley T. Accounting for noncompliance in pharmacoeconomic evaluations. Pharmacoeconomics 2001;19:1185-97. [PMID: 11772154 DOI: 10.2165/00019053-200119120-00001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
395 Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 2008;14:203-10. [PMID: 18381183 DOI: 10.1016/j.cardfail.2007.11.005] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 7.8] [Reference Citation Analysis]
396 Kawashima M, Nemoto O, Honda M, Watanabe D, Nakayama J, Imafuku S, Kato T, Katsuramaki T; study investigators. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study. J Dermatol 2017;44:1219-27. [PMID: 28681394 DOI: 10.1111/1346-8138.13948] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
397 Forni Ogna V, Pruijm M, Zweiacker C, Wuerzner G, Tousset E, Burnier M. Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. Biomed Res Int 2013;2013:104892. [PMID: 23971019 DOI: 10.1155/2013/104892] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
398 Jansen PA, Brouwers JR. Clinical pharmacology in old persons. Scientifica (Cairo) 2012;2012:723678. [PMID: 24278735 DOI: 10.6064/2012/723678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
399 Wurst KE, St Laurent S, Mullerova H, Davis KJ. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis 2014;9:1021-31. [PMID: 25285002 DOI: 10.2147/COPD.S58258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
400 Shellmer DA, Dabbs AD, Dew MA. Medical adherence in pediatric organ transplantation: what are the next steps? Curr Opin Organ Transplant 2011;16:509-14. [PMID: 21836517 DOI: 10.1097/MOT.0b013e32834a8c89] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
401 McHorney CA, Crivera C, Laliberté F, Germain G, Wynant W, Lefebvre P. Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users. PLoS One 2018;13:e0194099. [PMID: 29621248 DOI: 10.1371/journal.pone.0194099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
402 Grimmsmann T, Himmel W. Comparison of therapy persistence for fixed versus free combination antihypertensives: a retrospective cohort study. BMJ Open 2016;6:e011650. [PMID: 27881519 DOI: 10.1136/bmjopen-2016-011650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
403 Ostojic SM, Niess B, Stojanovic M, Obrenovic M. Creatine metabolism and safety profiles after six-week oral guanidinoacetic acid administration in healthy humans. Int J Med Sci 2013;10:141-7. [PMID: 23329885 DOI: 10.7150/ijms.5125] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
404 Flack JM, Nasser SA. Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag 2011;7:777-87. [PMID: 22241952 DOI: 10.2147/VHRM.S17207] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
405 Stark S, Snetselaar L, Hall B, Stone RA, Kim S, Piraino B, Sevick MA. Nutritional Intake in Adult Hemodialysis Patients. Top Clin Nutr 2011;26:45-56. [PMID: 25104876 DOI: 10.1097/TIN.0b013e3181faba4c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
406 Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertens Res 2019;42:249-56. [PMID: 30443023 DOI: 10.1038/s41440-018-0127-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
407 Matsui D. Current issues in pediatric medication adherence. Paediatr Drugs 2007;9:283-8. [PMID: 17927300 DOI: 10.2165/00148581-200709050-00001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
408 Darbà J, Ramírez G, Sicras A, Francoli P, Torvinen S, Sánchez-de la Rosa R. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Int J Chron Obstruct Pulmon Dis 2015;10:2335-45. [PMID: 26604733 DOI: 10.2147/COPD.S90155] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
409 Israni A, Dean CE, Salkowski N, Li S, Ratner LE, Rabb H, Powe NR, Kim SJ. Variation in structure and delivery of care between kidney transplant centers in the United States. Transplantation 2014;98:520-8. [PMID: 24825518 DOI: 10.1097/TP.0000000000000094] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
410 Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR. Recent advances in "smart" delivery systems for extended drug release in cancer therapy. Int J Nanomedicine 2018;13:4727-45. [PMID: 30154657 DOI: 10.2147/IJN.S168053] [Cited by in Crossref: 79] [Cited by in F6Publishing: 28] [Article Influence: 26.3] [Reference Citation Analysis]
411 Horne R. Is once enough? Understanding the preferences of COPD and asthma patients for once- versus twice-daily treatment. Prim Care Respir J 2013;22:140-2. [PMID: 23708114 DOI: 10.4104/pcrj.2013.00053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
412 Böhm SK, Kruis W. Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis. Clin Exp Gastroenterol 2014;7:369-83. [PMID: 25285021 DOI: 10.2147/CEG.S35691] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
413 Sengstock D, Vaitkevicius P, Salama A, Mentzer RM. Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence. Drugs Aging 2012;29:93-103. [PMID: 22239673 DOI: 10.2165/11598500-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
414 Lavan R, Armstrong R, Tunceli K, Normile D. Dog owner flea/tick medication purchases in the USA. Parasit Vectors 2018;11:581. [PMID: 30400923 DOI: 10.1186/s13071-018-3142-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
415 Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E, Wolff AC, Wang X, Kastrissios H, Berry D, Hudis C, Winer E, Muss H. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010;28:2418-2422. [PMID: 20368559 DOI: 10.1200/jco.2009.26.4671] [Cited by in Crossref: 81] [Cited by in F6Publishing: 28] [Article Influence: 7.4] [Reference Citation Analysis]
416 Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638-645. [PMID: 15209602 DOI: 10.1111/j.1525-1497.2004.30516.x] [Cited by in Crossref: 193] [Cited by in F6Publishing: 168] [Article Influence: 12.1] [Reference Citation Analysis]
417 Cvetković RS, Wellington K. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs 2005;65:859-78. [PMID: 15819597 DOI: 10.2165/00003495-200565060-00012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
418 Toida T, Toida R, Takahashi R, Uezono S, Komatsu H, Sato Y, Fujimoto S. Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study. Clin Exp Nephrol 2021. [PMID: 34129133 DOI: 10.1007/s10157-021-02094-9] [Reference Citation Analysis]
419 McClintock HF, BeKampis AN, Hartmann E, Bogner HR. Adherence to Antidepressants in Underserved Communities: A Comparison of Electronic Monitoring and Self-report Measures. Community Ment Health J 2020;56:727-34. [PMID: 31894439 DOI: 10.1007/s10597-019-00533-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
420 Bianchi C, Daniele G, Dardano A, Miccoli R, Del Prato S. Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes. Drugs 2017;77:247-64. [PMID: 28155046 DOI: 10.1007/s40265-017-0694-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
421 Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res 2013;11:54-65. [PMID: 23580788 DOI: 10.3121/cmr.2013.1113] [Cited by in Crossref: 185] [Cited by in F6Publishing: 139] [Article Influence: 23.1] [Reference Citation Analysis]
422 Markley HG, Dunteman ED, Kareht S, Sweeney M. Real-world experience with once-daily gabapentin for the treatment of postherpetic neuralgia (PHN). Clin J Pain 2015;31:58-65. [PMID: 25076463 DOI: 10.1097/AJP.0000000000000082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
423 Kim S, Bennett K, Wallace E, Fahey T, Cahir C. Measuring medication adherence in older community-dwelling patients with multimorbidity. Eur J Clin Pharmacol 2018;74:357-64. [PMID: 29199370 DOI: 10.1007/s00228-017-2388-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
424 Greenfield S. Comparative effectiveness and the future of clinical research in diabetes. Diabetes Care 2013;36:2146-7. [PMID: 23881966 DOI: 10.2337/dc13-1221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
425 Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Int J Chron Obstruct Pulmon Dis 2017;12:2929-42. [PMID: 29062230 DOI: 10.2147/COPD.S136256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
426 Tan J, Luo L, Zhang M, Chen H, Zhang D, Dong C, Xia B, Fu L, Tang F, Liu X, Tan Q, Wu Y. A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease. Patient Prefer Adherence 2019;13:1487-95. [PMID: 31507316 DOI: 10.2147/PPA.S207693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
427 Prado-Aguilar CA, Martínez YV, Segovia-Bernal Y, Reyes-Martínez R, Arias-Ulloa R. Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetes. BMC Public Health 2009;9:38. [PMID: 19171059 DOI: 10.1186/1471-2458-9-38] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
428 Valgimigli M, Garcia-Garcia HM, Vrijens B, Vranckx P, McFadden EP, Costa F, Pieper K, Vock DM, Zhang M, Van Es GA, Tricoci P, Baber U, Steg G, Montalescot G, Angiolillo DJ, Serruys PW, Farb A, Windecker S, Kastrati A, Colombo A, Feres F, Jüni P, Stone GW, Bhatt DL, Mehran R, Tijssen JGP. Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). Eur Heart J 2019;40:2070-85. [PMID: 29992264 DOI: 10.1093/eurheartj/ehy377] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
429 Ofori-Asenso R, Agyeman AA. Irrational Use of Medicines-A Summary of Key Concepts. Pharmacy (Basel) 2016;4:E35. [PMID: 28970408 DOI: 10.3390/pharmacy4040035] [Cited by in Crossref: 65] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
430 Mixon AS, Neal E, Bell S, Powers JS, Kripalani S. Care transitions: a leverage point for safe and effective medication use in older adults--a mini-review. Gerontology 2015;61:32-40. [PMID: 25277280 DOI: 10.1159/000363765] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
431 Hans G, Robert D. Transdermal buprenorphine - a critical appraisal of its role in pain management. J Pain Res 2009;2:117-34. [PMID: 21197300 DOI: 10.2147/jpr.s6503] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
432 Berends SE, Strik AS, Löwenberg M, D'Haens GR, Mathôt RAA. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clin Pharmacokinet 2019;58:15-37. [PMID: 29752633 DOI: 10.1007/s40262-018-0676-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 30.0] [Reference Citation Analysis]
433 Dolph M, Tremblay G, Leong H. US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma. Clinicoecon Outcomes Res 2021;13:493-502. [PMID: 34140789 DOI: 10.2147/CEOR.S305830] [Reference Citation Analysis]
434 Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, Brodovicz K, Alexander CM, Davies M, Iglay K, Zhang Q, Radican L. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence 2013;7:937-49. [PMID: 24086104 DOI: 10.2147/PPA.S43465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
435 Vogelmeier C, Ramos-Barbon D, Jack D, Piggott S, Owen R, Higgins M, Kramer B; INTIME study investigators (INdacaterol & TIotropium: Measuring Efficacy). Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respir Res 2010;11:135. [PMID: 20920365 DOI: 10.1186/1465-9921-11-135] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
436 Aoki T, Yamamoto Y, Ikenoue T, Onishi Y, Fukuhara S. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population. Sci Rep 2018;8:3806. [PMID: 29491441 DOI: 10.1038/s41598-018-21917-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
437 Fan T, Zhang Q, Sen SS. Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database. Clinicoecon Outcomes Res 2013;5:589-95. [PMID: 24277989 DOI: 10.2147/CEOR.S39076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
438 Pantuzza LL, Ceccato MDGB, Silveira MR, Junqueira LMR, Reis AMM. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73:1475-1489. [PMID: 28779460 DOI: 10.1007/s00228-017-2315-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
439 Awad A, Osman N, Altayib S. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study. Cardiovasc J Afr 2017;28:350-5. [PMID: 28345729 DOI: 10.5830/CVJA-2017-016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
440 Yang J, Yoon BM, Lee MS, Joe SH, Jung IK, Kim SH. Adherence with electronic monitoring and symptoms in children with attention deficit hyperactivity disorder. Psychiatry Investig 2012;9:263-8. [PMID: 22993526 DOI: 10.4306/pi.2012.9.3.263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
441 Kyriazis M. The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers. Rejuvenation Res. 2014;17:390-396. [PMID: 25072550 DOI: 10.1089/rej.2014.1588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
442 Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 2009;101:34-41. [PMID: 19058926 DOI: 10.1016/j.drugalcdep.2008.10.016] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 6.5] [Reference Citation Analysis]
443 Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gómez N, Yelmo S, Ferrer M, Martínez Y, Casas M. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 2008;22:603-11. [PMID: 18547128 DOI: 10.2165/00023210-200822070-00005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
444 Ye B, van Langenberg DR. Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? World J Gastrointest Pharmacol Ther. 2015;6:137-144. [PMID: 26558148 DOI: 10.4292/wjgpt.v6.i4.137] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
445 Jankowska-Polańska B, Zamęta K, Uchmanowicz I, Szymańska-Chabowska A, Morisky D, Mazur G. Adherence to pharmacological and non-pharmacological treatment of frail hypertensive patients. J Geriatr Cardiol 2018;15:153-61. [PMID: 29662509 DOI: 10.11909/j.issn.1671-5411.2018.02.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
446 Laliberté F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient 2013;6:213-24. [PMID: 23857628 DOI: 10.1007/s40271-013-0020-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
447 Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 2010;5:401-6. [PMID: 21191434 DOI: 10.2147/COPD.S14715] [Cited by in Crossref: 70] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
448 Pozdnyakov YM; study investigators. Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris. Cardiol Ther 2018;7:61-70. [PMID: 29779201 DOI: 10.1007/s40119-018-0110-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
449 Josiah Willock R, Miller JB, Mohyi M, Abuzaanona A, Muminovic M, Levy PD. Therapeutic Inertia and Treatment Intensification. Curr Hypertens Rep 2018;20:4. [PMID: 29380142 DOI: 10.1007/s11906-018-0802-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
450 Cowan R, Cohen JM, Rosenman E, Iyer R. Physician and patient preferences for dosing options in migraine prevention. J Headache Pain 2019;20:50. [PMID: 31072307 DOI: 10.1186/s10194-019-0998-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
451 Zayed HS, Medhat BM, Seif EM. Evaluation of treatment adherence in patients with Behçet's disease: its relation to disease manifestations, patients' beliefs about medications, and quality of life. Clin Rheumatol 2019;38:761-8. [PMID: 30367312 DOI: 10.1007/s10067-018-4344-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
452 Kelly M, McCarthy S, Sahm LJ. Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature. Eur J Clin Pharmacol 2014;70:1423-31. [PMID: 25277162 DOI: 10.1007/s00228-014-1761-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
453 Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One 2021;16:e0255642. [PMID: 34343225 DOI: 10.1371/journal.pone.0255642] [Reference Citation Analysis]
454 Bryant KB, Sheppard JP, Ruiz-Negrón N, Kronish IM, Fontil V, King JB, Pletcher MJ, Bibbins-Domingo K, Moran AE, McManus RJ, Bellows BK. Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure Control. J Am Heart Assoc 2020;9:e016174. [PMID: 32696695 DOI: 10.1161/JAHA.120.016174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
455 Astuti N, Maggiolo F. Single-Tablet Regimens in HIV Therapy. Infect Dis Ther 2014;3:1-17. [PMID: 25134808 DOI: 10.1007/s40121-014-0024-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
456 Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S; Treatment of Osteoporosis in clinical Practice (TOP) Study Group. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006;17:914-21. [PMID: 16538553 DOI: 10.1007/s00198-006-0073-6] [Cited by in Crossref: 201] [Cited by in F6Publishing: 143] [Article Influence: 13.4] [Reference Citation Analysis]
457 Degl' Innocenti A, Guyatt GH, Wiklund I, Heels-Ansdell D, Armstrong D, Fallone CA, Tanser L, van Zanten SV, El-Dika S, Chiba N, Barkun AN, Austin P, Schünemann HJ. The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes 2005;3:4. [PMID: 15649314 DOI: 10.1186/1477-7525-3-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
458 Bazargan M, Smith J, Movassaghi M, Martins D, Yazdanshenas H, Salehe Mortazavi S, Orum G. Polypharmacy among Underserved Older African American Adults. J Aging Res 2017;2017:6026358. [PMID: 28630771 DOI: 10.1155/2017/6026358] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
459 Dickson VV, Knafl GJ, Wald J, Riegel B. Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure. J Am Heart Assoc 2015;4:e001561. [PMID: 25870187 DOI: 10.1161/JAHA.114.001561] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
460 Kuipers JG, Koller M, Zeman F, Müller K, Rüffer JU. Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis : Analyses of a large-scale observational study. Z Rheumatol 2019;78:74-81. [PMID: 29691685 DOI: 10.1007/s00393-018-0449-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
461 Marek KD, Stetzer F, Ryan PA, Bub LD, Adams SJ, Schlidt A, Lancaster R, O'Brien AM. Nurse care coordination and technology effects on health status of frail older adults via enhanced self-management of medication: randomized clinical trial to test efficacy. Nurs Res 2013;62:269-78. [PMID: 23817284 DOI: 10.1097/NNR.0b013e318298aa55] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
462 Zeller A, Schroeder K, Peters TJ. Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care. Scand J Prim Health Care 2007;25:202-7. [PMID: 17924286 DOI: 10.1080/02813430701651954] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
463 Carvajal C. Poor response to treatment: beyond medication. Dialogues Clin Neurosci 2004;6:93-103. [PMID: 22034452 [PMID: 22034452 DOI: 10.31887/dcns.2004.6.1/ccarvajal] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
464 Fissell RB, Karaboyas A, Bieber BA, Sen A, Li Y, Lopes AA, Akiba T, Bommer J, Ethier J, Jadoul M, Pisoni RL, Robinson BM, Tentori F. Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS. Hemodial Int 2016;20:38-49. [PMID: 25975222 DOI: 10.1111/hdi.12315] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
465 Wang S, Alfieri T, Ramakrishnan K, Braunhofer P, Newsome BA. Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis. Nephrol Dial Transplant 2014;29:2092-9. [PMID: 24009281 DOI: 10.1093/ndt/gft280] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
466 Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009;66:1253-62. [PMID: 19884613 DOI: 10.1001/archgenpsychiatry.2009.142] [Cited by in Crossref: 163] [Cited by in F6Publishing: 130] [Article Influence: 13.6] [Reference Citation Analysis]
467 Shellmer DA, Dew MA, Mazariegos G, DeVito Dabbs A. Development and field testing of Teen Pocket PATH(®), a mobile health application to improve medication adherence in adolescent solid organ recipients. Pediatr Transplant 2016;20:130-40. [PMID: 26916967 DOI: 10.1111/petr.12639] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
468 Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res 2015;15:153. [PMID: 25884193 DOI: 10.1186/s12913-015-0809-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
469 Arahata M, Asakura H. Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities. Clin Interv Aging 2018;13:1675-90. [PMID: 30237704 DOI: 10.2147/CIA.S174896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]